Guía Práctica Clínica para el Embarazo, Referencias

1. Merenstein GB, Weisman LE. Premature rupture of the membranes: neonatal
consequences. Semin Perinatol. 1996;20(5):375-80. Epub 1996/10/01.
2. Di Renzo GC RL, Facchinetti F, Antsaklis A, Breborowicz G, Gratacos E, et al. Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2011;24(5):659-67.
3. Mercer BM. Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstet Gynecol Clin North Am. 2005;32(3):411-28. Epub 2005/08/30.
4. ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2007;109(4):1007-19. Epub 2007/04/03.
5. Gomez-Marin J. Toxoplasma. In: Diaz FE, S; Franco, L; Jaramillo, JM; Maestre, A; Ospina, S; Robledo, C; Robledo, J;, editor. Microbiologia de las Infecciones Humanas2007. p. 384-99.
6. McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz. 2009;104(2):320-44. Epub 2009/05/12.
7. Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, et al. Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology. 2008;115(3):553-9 e8. Epub 2007/09/11.
8. McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006;42(10):1383-94. Epub 2006/04/19.
9. SYROCOT SG. Effectiveness of prenatal treatment for congenital toxoplasmosis: a metanalysis of individual patient’s data. Lancet. 2007;369:115-22.
10. Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. 2010;7(10). Epub 2010/10/23.
11. Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2(8):e277. Epub 2008/08/14.
12. Gomez-Marin JE. Toxoplasma strain nomenclature. J Infect Dis. 2009;200(6):1012; author reply -3. Epub 2009/08/19.
13. Gallego C, Saavedra-Matiz C, Gomez-Marin JE. Direct genotyping of animal and human isolates of Toxoplasma gondii from Colombia (South America). Acta Trop. 2006;97(2):161-7. Epub 2005/11/29.
14. Dubey JP, Su C, Cortes JA, Sundar N, Gomez-Marin JE, Polo LJ, et al. Prevalence of Toxoplasma gondii in cats from Colombia, South America and genetic characterization of T. gondii isolates. Vet Parasitol. 2006;141(1-2):42-7. Epub 2006/06/27.
15. Morisset S, Peyron F, Lobry JR, Garweg J, Ferrandiz J, Musset K, et al. Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America. Microbes Infect. 2008;10(7):742-7. Epub 2008/06/10.
16. Gomez-Marin JE, Montoya-de-Londono MT, Castano-Osorio JC. A maternal screening program for congenital toxoplasmosis in Quindio, Colombia and application of mathematical models to estimate incidences using age-stratified data. Am J Trop Med Hyg. 1997;57(2):180-6. Epub 1997/08/01.
17. Juliao O CA, Moreno GS Estudio Nacional de Salud: Toxoplasmosis en Colombia. Ministerio de Salud Bogota: Imprenta Instituto Nacional de Salud. 1988.
18. Gomez-Marin JE, de-la-Torre A, Angel-Muller E, Rubio J, Arenas J, Osorio E, et al. First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl Trop Dis. 2011;5(5):1195. Epub 2011/06/10.
19. OPS. Mas alla de la supervivencia: Pracwcas integrales durante la atencion del parto, benexciosas para la nutricion y la salud de madres y ninos. . In: Salud OPdl, editor. Washington, D.C.: World Health Organization; 2007.
20. WHO. WHO Technical consultation on postpartum and postnatal care. Safer DoMP, editor. Geneva, Switzerland: WHO Document Production Services; 2010. 65 p.
21. WHO, UNICEF, UNFPA, Bank. W. Trends in Maternal Mortality: 1990 – 2008. Geneva: WHO Library Cataloguing-in-Publication Data; 2010 [cited 2011. Available from: http://whqlibdoc.who.int/publications/2010/9789241500265_eng.pdf.
22. WHO. World Health Organization Health and the Milennium Development Goals. Geneva: World Health Organization; 2005.
23. van den Broek NR, Falconer AD. Maternal mortality and Millennium Development Goal 5. Br Med Bull. 2011;99:25-38. Epub 2011/09/07.
24. WHO. Millennium development goals. World Health Organization; 2011 [cited 2011 11/2011]; Available from: http://www.who.int/topics/millennium_development_goals/maternal_health/en/index.html.
25. Lozano R, Wang H, Foreman KJ, Rajaratnam JK, Naghavi M, Marcus JR, et al. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet. 2011;378(9797):1139-65. Epub 2011/09/23.
26. WHO U, UNFPA, Bank. W. Trends in Maternal Mortality: 1990 – 2008: WHO Library Cataloguing-in-Publication Data; 2010 Jan 2012]. Available from:
http://whqlibdoc.who.int/publications/2010/9789241500265_eng.pdf.
27. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008;22(6):999-1012. Epub 2008/09/30.
28. Alcaldia de Medellin. Salud sexual y reproductiva- Universidad de Antioquia. Informe final de la vigilancia epidemiologica de la Morbilidad Obstetrica Severa en la ciudad de Medellin. Medellin: Secretaria de Salud- Direccion de Salud Publica. Nacer Salud sexual y reproductiva-Universidad de Antioquia; 2008.
29. Lalonde A, Daviss BA, Acosta A, Herschderfer K. Postpartum hemorrhage today: ICM/FIGO initiative 2004-2006. Int J Gynaecol Obstet. 2006;94(3):243-53. Epub 2006/07/18.
30. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ. 2001;322(7294):1089-93; discussion 93-4. Epub 2001/05/05.
31. Ministerio de la Proteccion Social- COLCIENCIAS-CEIS. Guia Metodologica para la elaboracion de Guias de Atencion Integral en el Sistema General de Seguridad Social en Salud Colombiano. Bogota, Colombia2010. 393 p.
32. Grupo de trabajo sobre GPC. Elaboracion de Guias de Practica Clinica en el Sistema Nacional de Salud. Manual Metodologico. Madrid: Plan Nacional para el SNS del MSC. Instituto Aragones de Ciencias de la Salud-I+CS 2007; 2006.
33. Association of the Scientific Medical Societies in Germany- Agency for Quality in Medicine. German Instrument for Methodological Guideline Appraisal. Berlin, Germany2008 [cited 2012 Jan 1]. Available from: www.english.delbi.de.
34. NICE – National Institute for Health and Clinical Excellence. Antenatal care: routine care for the healthy pregnant woman. London: RCOG Press; 2008 [cited 2011 Jun 1]. Available from: http://www.nice.org.uk/CG62.
35. National Collaborating Centre for Women’s and Children’s Health-National Institute for Health and Clinical Excellence. Hypertension in pregnancy. London: Royal College of Obstetricians and Gynaecologists; 2010 [cited 2011 Sept 1]. Available from: http://www.nice.org.uk/cg107.
36. Grupo de trabajo de la Guia de Practica Clinica sobre Atencion al Parto Normal. Guia de Practica Clinica sobre la Atencion al Parto Normal. Bilbao: Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Politica Social. Agencia de Evaluacion de Tecnologias Sanitarias del Pais Vasco (OSTEBA). Agencia de Evaluacion de Tecnologias Sanitarias de Galicia (Avalia-t). 2009 [cited 2011 Jun 1]. Available from: http://portal.guiasalud.es/web/guest/catalogogpc?p_p_id=EXT_8_INSTANCE_YIe8&p_p_lifecycle=0&p_p_state=maximized&p_p_mode=view&p_p_col_id=column-3&p_p_col_pos=1&p_p_col_count=2&_EXT_8_INSTANCE_YIe8_struts_action=%2Fext%2Fpredisenyada%2Fvista_Previa&_EXT_8_INSTANCE_YIe8_contenidoId=57717&_EXT_8_INSTANCE_YIe8_version=1.5.
37. Royal College of Obstetricians and Gynaecologists. Preterm Prelabour Rupture of Membranes. Dublin, Ireland2006 [cited 2011 Jun 1]. Available from:
http://www.rcog.org.uk/womens-health/clinical-guidance/preterm-prelabour-rupturemembranes-green-top-44.
38. World Health Organization. WHO guidelines for the management of postpartum
haemorrhage and retained placenta. Geneve: WHO Press; 2009 [cited 2011 Jun 1]. Available from: http://whqlibdoc.who.int/publications/2009/9789241598514_eng.pdf.
39. Royal College of Obstetricians and Gynaecologists. Prevention and Management of Postpartum Haemorrhage. London2009 [cited 2011 Jun 01]. Available from:
http://www.rcog.org.uk/womens-health/clinical-guidance/prevention-and-managementpostpartum-haemorrhage-green-top-52.
40. New Zealand Guidelines Group. Notes on the adaptation/Synthesis of Guidelines. New Zealand2004 [cited 2009 Jan 29]. Available from: www.nzgg.org.nz.
41. Schunemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation. Health Res Policy Syst. 2006;4:25. Epub 2006/12/13.
42. Scottish Intercollegiate Guidelines Network. SIGN 50: A guideline developer’s handbook. Edinburgh2008 [cited 2012 Jan 01]. Available from:
http://www.sign.ac.uk/guidelines/fulltext/50/index.html.
43. National Institute for Clinical Excellence. The guidelines manual. London: National Institute for Clinical Excellence; 2007 [cited 2012 Jan 01]. Available from:
http://www.nice.org.uk/aboutnice/howwework/developingniceclinicalguidelines/clinicalguidelinedevelopmentmethods/theguidelinesmanual2007/the_guidelines_manual_2007.jsp.
44. Villar J, Khan-Neelofur D. Patterns of routine antenatal care for low-risk pregnancy. Cochrane Database Syst Rev. 2000(2):CD000934. Epub 2000/05/05.
45. Hodnett ED. Continuity of caregivers for care during pregnancy and childbirth. Cochrane Database Syst Rev. 2000(2):CD000062. Epub 2000/05/05.
46. Hatem M, Sandall J, Devane D, Soltani H, Gates S. Midwife-led versus other models of care for childbearing women. Cochrane Database Syst Rev. 2008(4):CD004667. Epub 2008/10/10.
47. OMS. Ensayo clinico aleatorizado de control prenatal de la OMS: Manual para la puesta en practica del nuevo modelo de control prenatal. 2002.
48. Dowswell T, Carroli G, Duley L, Gates S, Gulmezoglu AM, Khan-Neelofur D, et al. Alternative versus standard packages of antenatal care for low-risk pregnancy. Cochrane Database Syst Rev. 2010(10):CD000934. Epub 2010/10/12.
49. Carroli G, Villar J, Piaggio G, Khan-Neelofur D, Gulmezoglu M, Mugford M, et al. WHO systematic review of randomised controlled trials of routine antenatal care. Lancet. 2001;357(9268):1565-70. Epub 2001/05/30.
50. Majoko F, Munjanja SP, Nystrom L, Mason E, Lindmark G. Randomised controlled trial of two antenatal care models in rural Zimbabwe. BJOG. 2007;114(7):802-11. Epub 2007/06/15.
51. Lilford RJ, Kelly M, Baines A, Cameron S, Cave M, Guthrie K, et al. Effect of using protocols on medical care: randomised trial of three methods of taking an antenatal history. BMJ. 1992;305(6863):1181-4. Epub 1992/11/14.
52. Lovell A, Zander LI, James CE, Foot S, Swan AV, Reynolds A. The St. Thomas’s Hospital maternity case notes study: a randomised controlled trial to assess the effects of giving expectant mothers their own maternity case notes. Paediatr Perinat Epidemiol. 1987;1(1):57-66. Epub 1987/04/01.
53. Brown HC, Smith HJ. Giving women their own case notes to carry during pregnancy.Cochrane Database Syst Rev. 2004(2):CD002856. Epub 2004/04/24.
54. Priest SR, Austin MP, Barnett BB, Buist A. A psychosocial risk assessment model (PRAM) for use with pregnant and postpartum women in primary care settings. Arch Womens Ment Health. 2008;11(5-6):307-17. Epub 2008/08/30.
55. Nelson HD, Nygren P, McInerney Y, Klein J. Screening women and elderly adults for family and intimate partner violence: a review of the evidence for the U. S. Preventive Services Task Force. Ann Intern Med. 2004;140(5):387-96. Epub 2004/03/05.
56. Carroll JC, Reid AJ, Biringer A, Midmer D, Glazier RH, Wilson L, et al. Effectiveness of the Antenatal Psychosocial Health Assessment (ALPHA) form in detecting psychosocial concerns: a randomized controlled trial. CMAJ. 2005;173(3):253-9. Epub 2005/08/04.
57. Webster J, Holt V. Screening for partner violence: direct questioning or self-report? Obstet Gynecol. 2004;103(2):299-303. Epub 2004/02/03.
58. Stahl K, Hundley V. Risk and risk assessment in pregnancy – do we scare because we care? Midwifery. 2003;19(4):298-309. Epub 2003/11/19.
59. Roy-Matton N, Moutquin JM, Brown C, Carrier N, Bell L. The impact of perceived maternal stress and other psychosocial risk factors on pregnancy complications. J Obstet Gynaecol Can. 2011;33(4):344-52. Epub 2011/04/20.
60. Austin MP, Priest SR, Sullivan EA. Antenatal psychosocial assessment for reducing perinatal mental health morbidity. Cochrane Database Syst Rev. 2008(4):CD005124. Epub 2008/10/10.
61. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67(10):1012-24. Epub 2010/10/06.
62. Reddy UM, Laughon SK, Sun L, Troendle J, Willinger M, Zhang J. Prepregnancy risk factors for antepartum stillbirth in the United States. Obstet Gynecol. 2010;116(5):1119-26. Epub 2010/10/23.
63. McCowan LM, Roberts CT, Dekker GA, Taylor RS, Chan EH, Kenny LC, et al. Risk factors for small-for-gestational-age infants by customised birthweight centiles: data from an international prospective cohort study. BJOG. 2010;117(13):1599-607. Epub 2010/11/17.
64. Kashanian M, Baradaran HR, Bahasadri S, Alimohammadi R. Risk factors for pre-eclampsia: a study in Tehran, Iran. Arch Iran Med. 2011;14(6):412-5. Epub 2011/11/02.
65. Ip M, Peyman E, Lohsoonthorn V, Williams MA. A case-control study of preterm delivery risk factors according to clinical subtypes and severity. J Obstet Gynaecol Res. 2010;36(1):34-44. Epub 2010/02/25.
66. Shechter Y, Levy A, Wiznitzer A, Zlotnik A, Sheiner E. Obstetric complications in grand and great grand multiparous women. J Matern Fetal Neonatal Med. 2010;23(10):1211-7. Epub 2010/04/21.
67. Heras Perez B GTJ, Mora Cepeda P, Almaraz Gomez A. La edad materna como factor de riesgo obstetrico. Resultados perinatales en gestantes de edad avanzada. Prog Obstet Ginecol. 2011;doi:10.1016/j.pog(06.012).
68. Flenady V, Koopmans L, Middleton P, Froen JF, Smith GC, Gibbons K, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet. 2011;377(9774):1331-40. Epub 2011/04/19.
69. Lu MC, Tache V, Alexander GR, Kotelchuck M, Halfon N. Preventing low birth weight: is prenatal care the answer? J Matern Fetal Neonatal Med. 2003;13(6):362-80. Epub 2003/09/10.
70. Carroli G, Rooney C, Villar J. How effective is antenatal care in preventing maternal mortality and serious morbidity? An overview of the evidence. Paediatr Perinat Epidemiol. 2001;15 Suppl 1:1-42. Epub 2001/03/13.
71. Chen MJ, Grobman WA, Gollan JK, Borders AE. The use of psychosocial stress scales in preterm birth research. Am J Obstet Gynecol. 2011;205(5):402-34. Epub 2011/08/06.
72. Spong CY, Landon MB, Gilbert S, Rouse DJ, Leveno KJ, Varner MW, et al. Risk of uterine rupture and adverse perinatal outcome at term after cesarean delivery. Obstet Gynecol. 2007;110(4):801-7. Epub 2007/10/02.
73. Stamilio DM, DeFranco E, Pare E, Odibo AO, Peipert JF, Allsworth JE, et al. Short interpregnancy interval: risk of uterine rupture and complications of vaginal birth after cesarean delivery. Obstet Gynecol. 2007;110(5):1075-82. Epub 2007/11/06.
74. Guise JM, Denman MA, Emeis C, Marshall N, Walker M, Fu R, et al. Vaginal birth after cesarean: new insights on maternal and neonatal outcomes. Obstet Gynecol. 2010;115(6):1267-78. Epub 2010/05/27.
75. Campbell MK, Carbone E, Honess-Morreale L, Heisler-Mackinnon J, Demissie S, Farrell D. Randomized trial of a tailored nutrition education CD-ROM program for women receiving food assistance. J Nutr Educ Behav. 2004;36(2):58-66. Epub 2004/04/08.
76. Olson CM, Strawderman MS, Reed RG. Efficacy of an intervention to prevent excessive gestational weight gain. Am J Obstet Gynecol. 2004;191(2):530-6. Epub 2004/09/03.
77. Gagnon AJ, Sandall J. Individual or group antenatal education for childbirth or parenthood, or both. Cochrane Database Syst Rev. 2007(3):CD002869. Epub 2007/07/20.
78. Lumley J, Oliver S, Waters E. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2000(2):CD001055. Epub 2000/05/05.
79. Lumley J, Chamberlain C, Dowswell T, Oliver S, Oakley L, Watson L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2009(3):CD001055. Epub 2009/07/10.
80. Gray R HJ. Review of the fetal effects of prenatal alcohol exposure. In: Unit NPE, editor. Oxford2006.
81. Mariscal M, Palma S, Llorca J, Perez-Iglesias R, Pardo-Crespo R, Delgado-Rodriguez M. Pattern of alcohol consumption during pregnancy and risk for low birth weight. Ann Epidemiol. 2006;16(6):432-8. Epub 2005/11/01.
82. Patra J, Bakker R, Irving H, Jaddoe VWV, Malini S, Rehm J. Dose-response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)-a systematic review and meta-analyses. BJOG: An International Journal of Obstetrics and Gynaecology. 2011;118(12):1411-21.
83. O’Reilly R, Beale B, Gillies D. Screening and intervention for domestic violence during pregnancy care: a systematic review. Trauma Violence Abuse. 2010;11(4):190-201. Epub 2010/08/07.
84. Dawes MG, Grudzinskas JG. Repeated measurement of maternal weight during pregnancy. Is this a useful practice? Br J Obstet Gynaecol. 1991;98(2):189-94. Epub 1991/02/01.
85. Siega-Riz AM, Adair LS, Hobel CJ. Maternal underweight status and inadequate rate of weight gain during the third trimester of pregnancy increases the risk of preterm delivery. J Nutr. 1996;126(1):146-53. Epub 1996/01/01.
86. Siega-Riz AM, Viswanathan M, Moos MK, Deierlein A, Mumford S, Knaack J, et al. A systematic review of outcomes of maternal weight gain according to the Institute of Medicine recommendations: birthweight, fetal growth, and postpartum weight retention. Am J Obstet Gynecol. 2009;201(4):339 e1-14. Epub 2009/10/01.
87. Cnossen JS, Leeflang MMG, de Haan EEM, Mol BWJ, van der Post JAM, Khan KS, et al. Accuracy of body mass index in predicting pre-eclampsia: bivariate meta-analysis. BJOG. 2007;114(12):1477-85. Epub 12.
88. Fortner RT, Pekow P, Solomon CG, Markenson G, Chasan-Taber L. Prepregnancy body mass index, gestational weight gain, and risk of hypertensive pregnancy among Latina women. American Journal of Obstetrics and Gynecology. 2009;200(2):167.e1-.e7.
89. Reiss RE, O’Shaughnessy RW, Quilligan TJ, Zuspan FP. Retrospective comparison of blood pressure course during preeclamptic and matched control pregnancies. Am J Obstet Gynecol. 1987;156(4):894-8. Epub 1987/04/01.
90. Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995;172(2 Pt 1):642-8. Epub 1995/02/01.
91. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. BJOG. 2000;107(11):1410-6. Epub 2000/12/16.
92. Stamilio DM SH, Morgan MA, Propert K, Macones GA. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? . American Journal of Obstetrics and Gynecology. 2000;182(589-94).
93. Cnossen JS, Vollebregt KC, De Vrieze N, Ter Riet G, Mol BWJ, Franx A, et al. Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: Systematic review and meta-analysis. BMJ. 2008;336(7653):1117-20.
94. Neilson JP. Symphysis-fundal height measurement in pregnancy. Cochrane Database Syst Rev. 2000(2):CD000944. Epub 2000/05/05. 95. Morse K, Williams A, Gardosi J. Fetal growth screening by fundal height measurement.
Best Pract Res Clin Obstet Gynaecol. 2009;23(6):809-18. Epub 2009/11/17.
96. Griffiths A, Pinto A, Margarit L. A survey of methods used to measure symphysis fundal height. J Obstet Gynaecol. 2008;28(7):692-4. Epub 2008/12/10.
97. Alexander JM, Grant AM, Campbell MJ. Randomised controlled trial of breast shells and Hoffman’s exercises for inverted and non-protractile nipples. BMJ. 1992;304(6833):1030-2. Epub 1992/04/18.
98. Lee SJ, Thomas J. Antenatal breast examination for promoting breastfeeding. Cochrane Database Syst Rev. 2008(3):CD006064. Epub 2008/07/23.
99. Pattinson RC. Pelvimetry for fetal cephalic presentations at term. Cochrane Database Syst Rev. 2000(2):CD000161. Epub 2000/05/05.
100. Lenihan JP, Jr. Relationship of antepartum pelvic examinations to premature rupture of the membranes. Obstet Gynecol. 1984;63(1):33-7. Epub 1984/01/01.
101. Alexander S, Boulvain M, Ceysens G, Haelterman E, Zhang WH. Repeat digital cervical assessment in pregnancy for identifying women at risk of preterm labour. Cochrane Database Syst Rev. 2010(6):CD005940. Epub 2010/06/18.
102. Newberger EH, Barkan SE, Lieberman ES, McCormick MC, Yllo K, Gary LT, et al. Abuse of pregnant women and adverse birth outcome. Current knowledge and implications for practice. JAMA. 1992;267(17):2370-2. Epub 1992/05/06.
103. Murphy CC, Schei B, Myhr TL, Du Mont J. Abuse: a risk factor for low birth weight? A systematic review and meta-analysis. CMAJ. 2001;164(11):1567-72. Epub 2001/06/14.
104. Cokkinides VE, Coker AL, Sanderson M, Addy C, Bethea L. Physical violence during pregnancy: maternal complications and birth outcomes. Obstet Gynecol. 1999;93(5 Pt 1):661-6. Epub 2000/07/27.
105. Janssen PA, Holt VL, Sugg NK, Emanuel I, Critchlow CM, Henderson AD. Intimate partner violence and adverse pregnancy outcomes: a population-based study. Am J Obstet Gynecol. 2003;188(5):1341-7. Epub 2003/05/16.
106. Wathen CN, MacMillan HL. Interventions for violence against women: scientific review. JAMA. 2003;289(5):589-600. Epub 2003/02/13.
107. Ramsay J, Richardson J, Carter YH, Davidson LL, Feder G. Should health professionals screen women for domestic violence? Systematic review. BMJ. 2002;325(7359):314. Epub 2002/08/10.
108. Lewis G, National Institute for Clinical E. Why mothers die 1997-1999: the fifth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom: Royal College of Obstetricians and Gynecologists; 2001.
109. Dayan J, Creveuil C, Herlicoviez M, Herbel C, Baranger E, Savoye C, et al. Role of anxiety and depression in the onset of spontaneous preterm labor. Am J Epidemiol. 2002;155(4):293-301. Epub 2002/02/12.
110. Lundy BL JN, Field T. Prenatal depression effects on neonates. Infant Behavior and Development. 1999;22(119-29).
111. Bolton HL, Hughes PM, Turton P, Sedgwick P. Incidence and demographic correlates of depressive symptoms during pregnancy in an inner London population. J Psychosom Obstet Gynaecol. 1998;19(4):202-9. Epub 1999/02/04.
112. Wilson LM, Reid AJ, Midmer DK, Biringer A, Carroll JC, Stewart DE. Antenatal psychosocial risk factors associated with adverse postpartum family outcomes. CMAJ. 1996;154(6):785-99. Epub 1996/03/15.
113. Austin MP, Lumley J. Antenatal screening for postnatal depression: a systematic review. Acta Psychiatr Scand. 2003;107(1):10-7. Epub 2003/02/01.
114. Hayes BA, Muller R, Bradley BS. Perinatal depression: a randomized controlled trial of an antenatal education intervention for primiparas. Birth. 2001;28(1):28-35. Epub 2001/03/27.
115. Brugha TS, Wheatley S, Taub NA, Culverwell A, Friedman T, Kirwan P, et al. Pragmatic randomized trial of antenatal intervention to prevent post-natal depression by reducing psychosocial risk factors. Psychol Med. 2000;30(6):1273-81. Epub 2000/11/30.
116. Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial. Obstet Gynecol. 2001;97(4):577-82. Epub 2001/03/29.
117. Aikins Murphy P. Alternative therapies for nausea and vomiting of pregnancy. Obstet Gynecol. 1998;91(1):149-55. Epub 1998/02/17.
118. Keating A, Chez RA. Ginger syrup as an antiemetic in early pregnancy. Altern Ther Health Med. 2002;8(5):89-91. Epub 2002/09/18.
119. Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2002(1):CD000145. Epub 2002/03/01.
120. Vickers AJ. Can acupuncture have specific effects on health? A systematic review of acupuncture antiemesis trials. J R Soc Med. 1996;89(6):303-11. Epub 1996/06/01.
121. Norheim AJ, Pedersen EJ, Fonnebo V, Berge L. Acupressure treatment of morning sickness in pregnancy. A randomised, double-blind, placebo-controlled study. Scand J Prim Health Care. 2001;19(1):43-7. Epub 2001/04/17.
122. Knight B, Mudge C, Openshaw S, White A, Hart A. Effect of acupuncture on nausea of pregnancy: a randomized, controlled trial. Obstet Gynecol. 2001;97(2):184-8. Epub 2001/02/13.
123. Werntoft E, Dykes AK. Effect of acupressure on nausea and vomiting during pregnancy. A randomized, placebo-controlled, pilot study. J Reprod Med. 2001;46(9):835-9. Epub 2001/10/05.
124. Smith C, Crowther C, Beilby J. Acupuncture to treat nausea and vomiting in early pregnancy: a randomized controlled trial. Birth. 2002;29(1):1-9. Epub 2002/02/15.
125. Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2003(4):CD000145. Epub 2003/10/30.
126. Magee LA, Mazzotta P, Koren G. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S256-61. Epub 2002/05/16.
127. Mazzotta P, Magee LA. A risk-benefit assessment of pharmacological and
nonpharmacological treatments for nausea and vomiting of pregnancy. Drugs. 2000;59(4):781- 800. Epub 2000/05/10.
128. Matthews A, Dowswell T, Haas DM, Doyle M, O’Mathuna DP. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2010(9):CD007575. Epub 2010/09/09. 129. Festin M. Nausea and vomiting in early pregnancy. Clin Evid (Online). 2009;2009. Epub 2009/01/01.
130. Marrero JM, Goggin PM, de Caestecker JS, Pearce JM, Maxwell JD. Determinants of pregnancy heartburn. Br J Obstet Gynaecol. 1992;99(9):731-4. Epub 1992/09/01.
131. Lang GD, Dougall A. Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy. Br J Clin Pract Suppl. 1989;66:48-51; discussion 61-4. Epub 1989/02/01.
132. Smith C, Crowther C, Beilby J. Pregnancy outcome following women’s participation in a randomised controlled trial of acupuncture to treat nausea and vomiting in early pregnancy. Complement Ther Med. 2002;10(2):78-83. Epub 2002/12/17.
133. Rayburn W, Liles E, Christensen H, Robinson M. Antacids vs. antacids plus non-prescription ranitidine for heartburn during pregnancy. Int J Gynaecol Obstet. 1999;66(1):35-7. Epub 1999/08/24.
134. Larson JD, Patatanian E, Miner PB, Jr., Rayburn WF, Robinson MG. Double-blind, placebocontrolled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet
Gynecol. 1997;90(1):83-7. Epub 1997/07/01.
135. Magee LA, Inocencion G, Kamboj L, Rosetti F, Koren G. Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study. Dig Dis Sci. 1996;41(6):1145-9. Epub 1996/06/01.
136. Nikfar S, Abdollahi M, Moretti ME, Magee LA, Koren G. Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Dig Dis Sci. 2002;47(7):1526-9. Epub 2002/07/27.
137. Dowswell T, Neilson JP. Interventions for heartburn in pregnancy. Cochrane Database Syst Rev. 2008(4):CD007065. Epub 2008/10/10.
138. Meyer LC, Peacock JL, Bland JM, Anderson HR. Symptoms and health problems in pregnancy: their association with social factors, smoking, alcohol, caffeine and attitude to pregnancy. Paediatr Perinat Epidemiol. 1994;8(2):145-55. Epub 1994/04/01.
139. Jewell DJ, Young G. Interventions for treating constipation in pregnancy. Cochrane Database Syst Rev. 2001(2):CD001142. Epub 2001/06/19.
140. Wijayanegara H, Mose JC, Achmad L, Sobarna R, Permadi W. A clinical trial of hydroxyethylrutosides in the treatment of haemorrhoids of pregnancy. J Int Med Res. 1992;20(1):54-60. Epub 1992/02/01.
141. Buckshee K, Takkar D, Aggarwal N. Micronized flavonoid therapy in internal hemorrhoids of pregnancy. Int J Gynaecol Obstet. 1997;57(2):145-51. Epub 1997/05/01.
142. Quijano CE, Abalos E. Conservative management of symptomatic and/or complicated haemorrhoids in pregnancy and the puerperium. Cochrane Database Syst Rev. 2005(3):CD004077. Epub 2005/07/22.
143. Saleeby RG, Jr., Rosen L, Stasik JJ, Riether RD, Sheets J, Khubchandani IT.
Hemorrhoidectomy during pregnancy: risk or relief? Dis Colon Rectum. 1991;34(3):260-1. Epub 1991/03/11.
144. Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol. 1999;181(4):1026-35. Epub 1999/10/16.
145. Thaler E, Huch R, Huch A, Zimmermann R. Compression stockings prophylaxis of emergent varicose veins in pregnancy: a prospective randomised controlled study. Swiss Med Wkly. 2001;131(45-46):659-62. Epub 2002/02/09.
146. Owens K, Pearson A, Mason G. Symphysis pubis dysfunction–a cause of significant obstetric morbidity. Eur J Obstet Gynecol Reprod Biol. 2002;105(2):143-6. Epub 2002/10/17.
147. Field T, Hernandez-Reif M, Hart S, Theakston H, Schanberg S, Kuhn C. Pregnant women benefit from massage therapy. J Psychosom Obstet Gynaecol. 1999;20(1):31-8. Epub 1999/04/23.
148. Ostgaard HC, Zetherstrom G, Roos-Hansson E, Svanberg B. Reduction of back and posterior pelvic pain in pregnancy. Spine (Phila Pa 1976). 1994;19(8):894-900. Epub 1994/04/15.
149. Noren L, Ostgaard S, Nielsen TF, Ostgaard HC. Reduction of sick leave for lumbar back and posterior pelvic pain in pregnancy. Spine (Phila Pa 1976). 1997;22(18):2157-60. Epub 1997/10/10.
150. Fry D, Hay-Smith J, Hough J, McIntosh J, Polden M, Shepherd J, et al. National clinical guidelines for the care of women with symphysis pubis dysfunction. Association of Chartered Physiotherapists in Women’s Health. Midwives. 1997;110(1314):172-3. Epub 1997/07/01.
151. Ee CC, Manheimer E, Pirotta MV, White AR. Acupuncture for pelvic and back pain in pregnancy: a systematic review. Am J Obstet Gynecol. 2008;198(3):254-9. Epub 2008/03/04.
152. Pennick VE, Young G. Interventions for preventing and treating pelvic and back pain in pregnancy. Cochrane Database Syst Rev. 2007(2):CD001139. Epub 2007/04/20.
153. Gould JS, Wissinger HA. Carpal tunnel syndrome in pregnancy. South Med J.
1978;71(2):144-5, 54. Epub 1978/02/01.
154. Padua L, Aprile I, Caliandro P, Carboni T, Meloni A, Massi S, et al. Symptoms and neurophysiological picture of carpal tunnel syndrome in pregnancy. Clin Neurophysiol. 2001;112(10):1946-51. Epub 2001/10/12.
155. Ortiz JR, Englund JA, Neuzil KM. Influenza vaccine for pregnant women in resourceconstrained countries: a review of the evidence to inform policy decisions. Vaccine. 2011;29(27):4439-52. Epub 2011/05/10.
156. Advisory Committee on Immunization Practices (ACIP). Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 20122012. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6125a4.htm.
157. Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-4):1-51. Epub 2008/05/30.
158. Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Hepatitis B vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev. 2011(3):CD007879. Epub 2011/03/18.
159. Staples JE, Gershman M, Fischer M. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59(RR-7):1-27. Epub 2010/07/31.
160. Rosenberg K, Grant JM, Tweedie I, Aitchison T, Gallagher F. Measurement of fundal height as a screening test for fetal growth retardation. Br J Obstet Gynaecol. 1982;89(6):447-50. Epub 1982/06/01.
161. Persson B, Stangenberg M, Lunell NO, Brodin U, Holmberg NG, Vaclavinkova V. Prediction of size of infants at birth by measurement of symphysis fundus height. Br J Obstet Gynaecol. 1986;93(3):206-11. Epub 1986/03/01.
162. Harding K, Evans S, Newnham J. Screening for the small fetus: a study of the relative efficacies of ultrasound biometry and symphysiofundal height. Aust N Z J Obstet Gynaecol. 1995;35(2):160-4. Epub 1995/05/01.
163. Grover V, Usha R, Kalra S, Sachdeva S. Altered fetal growth: antenatal diagnosis by symphysis-fundal height in India and comparison with western charts. Int J Gynaecol Obstet. 1991;35(3):231-4. Epub 1991/07/01.
164. Rogers MS, Needham PG. Evaluation of fundal height measurement in antenatal care. Aust N Z J Obstet Gynaecol. 1985;25(2):87-90. Epub 1985/05/01.
165. Okonofua FE, Ayangade SO, Chan RC, O’Brien PM. A prospective comparison of clinical and ultrasonic methods of predicting normal and abnormal fetal growth. Int J Gynaecol Obstet. 1986;24(6):447-51. Epub 1986/12/01.
166. Neilson James P. Symphysis-fundal height measurement in pregnancy. Cochrane Database of Systematic Reviews. 2009(1):CD000944.
167. Warsof SL, Cooper DJ, Little D, Campbell S. Routine ultrasound screening for antenatal detection of intrauterine growth retardation. Obstet Gynecol. 1986;67(1):33-9. Epub 1986/01/01.
168. Skovron ML, Berkowitz GS, Lapinski RH, Kim JM, Chitkara U. Evaluation of early thirdtrimester ultrasound screening for intrauterine growth retardation. J Ultrasound Med. 1991;10(3):153-9. Epub 1991/03/01.
169. Newnham JP, Patterson LL, James IR, Diepeveen DA, Reid SE. An evaluation of the efficacy of Doppler flow velocity waveform analysis as a screening test in pregnancy. Am J Obstet Gynecol. 1990;162(2):403-10. Epub 1990/02/01.
170. Lin CC, Sheikh Z, Lopata R. The association between oligohydramnios and intrauterine growth retardation. Obstet Gynecol. 1990;76(6):1100-4. Epub 1990/12/01.
171. Hedriana HL, Moore TR. A comparison of single versus multiple growth ultrasonographic examinations in predicting birth weight. Am J Obstet Gynecol. 1994;170(6):1600-4; discussion 4-6. Epub 1994/06/01.
172. Ott WJ, Doyle S. Ultrasonic diagnosis of altered fetal growth by use of a normal ultrasonic fetal weight curve. Obstet Gynecol. 1984;63(2):201-4. Epub 1984/02/01.
173. Coomarasamy A, Connock M, Thornton J, Khan KS. Accuracy of ultrasound biometry in the prediction of macrosomia: a systematic quantitative review. BJOG. 2005;112(11):1461-6. Epub 2005/10/18.
174. Freire DMC, Cecatti JG, Paiva CSM. Correlation between estimated fetal weight by ultrasound and neonatal weight. Revista Brasileira de Ginecologia e Obstetricia. 2010;32(1):4-10.
175. Hargreaves K, Cameron M, Edwards H, Gray R, Deane K. Is the use of symphysis-fundal height measurement and ultrasound examination effective in detecting small or large fetuses? J Obstet Gynaecol. 2011;31(5):380-3. Epub 2011/06/02.
176. Kayem G, Grange G, Breart G, Goffinet F. Comparison of fundal height measurement and sonographically measured fetal abdominal circumference in the prediction of high and low birth weight at term. Ultrasound Obstet Gynecol. 2009;34(5):566-71. Epub 2009/07/08.
177. Beattie RB, Dornan JC. Antenatal screening for intrauterine growth retardation with umbilical artery Doppler ultrasonography. BMJ. 1989;298(6674):631-5. Epub 1989/03/11.
178. Todros T, Ferrazzi E, Arduini D, Bastonero S, Bezzeccheri V, Biolcati M, et al. Performance of Doppler ultrasonography as a screening test in low risk pregnancies: results of a multicentric study. J Ultrasound Med. 1995;14(5):343-8. Epub 1995/05/01.
179. Sijmons EA, Reuwer PJ, van Beek E, Bruinse HW. The validity of screening for small-forgestational-age and low-weight-for-length infants by Doppler ultrasound. Br J Obstet Gynaecol.
1989;96(5):557-61. Epub 1989/05/01.
180. Atkinson MW, Maher JE, Owen J, Hauth JC, Goldenberg RL, Copper RL. The predictive value of umbilical artery Doppler studies for preeclampsia or fetal growth retardation in a preeclampsia prevention trial. Obstet Gynecol. 1994;83(4):609-12. Epub 1994/04/01. 181. Bricker L, Garcia J, Henderson J, Mugford M, Neilson J, Roberts T, et al. Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women’s views. Health Technol Assess. 2000;4(16):i-vi, 1-193. Epub 2000/11/09.
182. Whitlow BJ, Chatzipapas IK, Lazanakis ML, Kadir RA, Economides DL. The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population. Br J Obstet Gynaecol. 1999;106(9):929-36. Epub 1999/09/24.
183. Srisupundit K, Tongsong T, Sirichotiyakul S, Chanprapaph P. Fetal structural anomaly screening at 11-14 weeks of gestation at Maharaj Nakorn Chiang Mai Hospital. J Med Assoc Thai. 2006;89(5):588-93. Epub 2006/06/08.
184. Cedergren M, Selbing A. Detection of fetal structural abnormalities by an 11-14-week ultrasound dating scan in an unselected Swedish population. Acta Obstet Gynecol Scand. 2006;85(8):912-5. Epub 2006/07/25.
185. Guariglia L, Rosati P. Transvaginal sonographic detection of embryonic-fetal abnormalities in early pregnancy. Obstet Gynecol. 2000;96(3):328-32. Epub 2000/08/29.
186. Randall P, Brealey S, Hahn S, Khan KS, Parsons JM. Accuracy of fetal echocardiography in the routine detection of congenital heart disease among unselected and low risk populations: a systematic review. BJOG. 2005;112(1):24-30. Epub 2005/01/25.
187. Buskens E, Grobbee DE, Frohn-Mulder IM, Stewart PA, Juttmann RE, Wladimiroff JW, et al. Efficacy of routine fetal ultrasound screening for congenital heart disease in normal pregnancy. Circulation. 1996;94(1):67-72. Epub 1996/07/01.
188. Tegnander E, Williams W, Johansen OJ, Blaas HG, Eik-Nes SH. Prenatal detection of heart defects in a non-selected population of 30,149 fetuses–detection rates and outcome. Ultrasound Obstet Gynecol. 2006;27(3):252-65. Epub 2006/02/04.
189. Crowther CA, Kornman L, O’Callaghan S, George K, Furness M, Willson K. Is an ultrasound assessment of gestational age at the first antenatal visit of value? A randomised clinical trial. Br J Obstet Gynaecol. 1999;106(12):1273-9. Epub 1999/12/28.
190. Olesen AW, Thomsen SG. Prediction of delivery date by sonography in the first and second trimesters. Ultrasound Obstet Gynecol. 2006;28(3):292-7. Epub 2006/07/26.
191. Taipale P, Hiilesmaa V. Predicting delivery date by ultrasound and last menstrual period in early gestation. Obstet Gynecol. 2001;97(2):189-94. Epub 2001/02/13.
192. Neufeld LM, Haas JD, Grajeda R, Martorell R. Last menstrual period provides the best estimate of gestation length for women in rural Guatemala. Paediatr Perinat Epidemiol. 2006;20(4):290-8. Epub 2006/08/02.
193. Mustafa G, David RJ. Comparative accuracy of clinical estimate versus menstrual gestational age in computerized birth certificates. Public Health Rep. 2001;116(1):15-21. Epub 2001/09/26.
194. Nguyen TH, Larsen T, Engholm G, Moller H. Evaluation of ultrasound-estimated date of delivery in 17,450 spontaneous singleton births: do we need to modify Naegele’s rule? Ultrasound Obstet Gynecol. 1999;14(1):23-8. Epub 1999/08/26.
195. Campbell S, Warsof SL, Little D, Cooper DJ. Routine ultrasound screening for the prediction of gestational age. Obstet Gynecol. 1985;65(5):613-20. Epub 1985/05/01.
196. Kopta MM, May RR, Crane JP. A comparison of the reliability of the estimated date of confinement predicted by crown-rump length and biparietal diameter. Am J Obstet Gynecol. 1983;145(5):562-5. Epub 1983/03/01.
197. Neilson JP. Ultrasound for fetal assessment in early pregnancy. Cochrane Database Syst Rev. 2000(2):CD000182. Epub 2000/05/05.
198. Waldenstrom U, Axelsson O, Nilsson S, Eklund G, Fall O, Lindeberg S, et al. Effects of routine one-stage ultrasound screening in pregnancy: a randomised controlled trial. Lancet. 1988;2(8611):585-8. Epub 1988/09/10.
199. Westin M, Saltvedt S, Bergman G, Kublickas M, Almstrom H, Grunewald C, et al. Routine ultrasound examination at 12 or 18 gestational weeks for prenatal detection of major congenital heart malformations? A randomised controlled trial comprising 36,299 fetuses. BJOG. 2006;113(6):675-82. Epub 2006/05/20.
200. Saltvedt S, Almstrom H, Kublickas M, Valentin L, Grunewald C. Detection of malformations in chromosomally normal fetuses by routine ultrasound at 12 or 18 weeks of gestation-a randomised controlled trial in 39,572 pregnancies. BJOG. 2006;113(6):664-74. Epub 2006/05/20.
201. Whitworth M, Bricker L, Neilson James P, Dowswell T. Ultrasound for fetal assessment in early pregnancy. Cochrane Database of Systematic Reviews. 2010(4):CD007058.
202. Rasiah SV, Publicover M, Ewer AK, Khan KS, Kilby MD, Zamora J. A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound Obstet Gynecol. 2006;28(1):110-6. Epub 2006/06/24.
203. Simpson LL, Malone FD, Bianchi DW, Ball RH, Nyberg DA, Comstock CH, et al. Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol. 2007;109(2 Pt 1):376-83. Epub 2007/02/03.
204. Maarse W, Berge SJ, Pistorius L, van Barneveld T, Kon M, Breugem C, et al. Diagnostic accuracy of transabdominal ultrasound in detecting prenatal cleft lip and palate: a systematic review. Ultrasound Obstet Gynecol. 2010;35(4):495-502. Epub 2010/03/18.
205. Bricker L, Neilson JP, Dowswell T. Routine ultrasound in late pregnancy (after 24 weeks’ gestation). Cochrane Database of Systematic Reviews. 2008(4).
206. S Vause JH, JG Thornton. Palpation or ultrasound for detecting breech babies? . British Journal of Midwifery. 1997;5(6):318- 9.
207. Thorp JM Jr JT, Watson W. Utility of Leopold maneuvers in screening for malpresentation. Obstetrics and Gynecology. 1991;78:394-6.
208. Olsen K. Midwife to midwife. ‘Now just pop up here, dear…’ revisiting the art of antenatal abdominal palpation. Practising Midwife. 1999;2:13–5.
209. Grant A ED, Valentin L, Alexander S. Routine formal fetal movement counting and risk of antepartum late death in normally formed singletons. Lancet. 1989;ii:345-9.
210. Mangesi L, Hofmeyr GJ. Fetal movement counting for assessment of fetal wellbeing. Cochrane Database Syst Rev. 2007(1):CD004909. Epub 2007/01/27.
211. Divanovic E BE. Routine heart and lung auscultation in prenatal care. International Journal of Gynecology and Obstetrics. 1999;64:247-51.
212. Sharif K WM. Routine antenatal fetal heart rate auscultation: is it necessary? Journal of Obstetrics and Gynaecology. 1993;13:111-3.
213. Garcia J CM, MacDonald D, Elbourne D, Grant A. Mothers’ views of continuous electronic fetal heart monitoring and intermittent auscultation in a randomized controlled trial. Birth. 1985;12(79–86).
214. Pattison N ML. Cardiotocography for antepartum fetal assessment. Cochrane Database of Systematic Reviews. 2001;2.
215. Haws RA, Yakoob MY, Soomro T, Menezes EV, Darmstadt GL, Bhutta ZA. Reducing stillbirths: screening and monitoring during pregnancy and labour. BMC Pregnancy Childbirth. 2009;9 Suppl 1:S5. Epub 2009/05/14.
216. Bricker L, Neilson JP. Routine ultrasound in late pregnancy (after 24 weeks gestation). Cochrane Database Syst Rev. 2000(2):CD001451. Epub 2000/05/05.
217. Stampalija T, Gyte GM, Alfirevic Z. Utero-placental Doppler ultrasound for improving pregnancy outcome. Cochrane Database Syst Rev. 2010(9):CD008363. Epub 2010/09/09.
218. Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ. 2008;178(6):701-11. Epub 2008/03/12.
219. Chang A, Magwene K, Frand E. Increased safety belt use following education in childbirth classes. Birth. 1987;14(3):148-52. Epub 1987/09/01.
220. Klinich KD, Schneider LW, Moore JL, Pearlman MD. Investigations of crashes involving pregnant occupants. Annu Proc Assoc Adv Automot Med. 2000;44:37-55. Epub 2001/09/18.
221. Crosby WM, Costiloe JP. Safety of lap-belt restraint for pregnant victims of automobile collisions. N Engl J Med. 1971;284(12):632-6. Epub 1971/03/25.
222. Crosby WM, King AI, Stout LC. Fetal survival following impact: improvement with shoulder harness restraint. Am J Obstet Gynecol. 1972;112(8):1101-6. Epub 1972/04/15.
223. Wolf M, Alexander B, Rivara F, Hickok D, RV RM. A retrospective cohort study of seatbelt use and pregnancy outcome after a motor vehicle crash. Journal of Trauma-Injury Infection and critical care. 1993;34:116-19.
224. James KV, Lohr JM, Deshmukh RM, Cranley JJ. Venous thrombotic complications of pregnancy. Cardiovasc Surg. 1996;4(6):777-82. Epub 1996/12/01.
225. McColl MD, Ramsay JE, Tait RC, Walker ID, McCall F, Conkie JA, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost. 1997;78(4):1183-8. Epub 1997/11/19.
226. Kierkegaard A. Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstet Gynecol Scand. 1983;62(3):239-43. Epub 1983/01/01.
227. Scurr JH, Machin SJ, Bailey-King S, Mackie IJ, McDonald S, Smith PD. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet. 2001;357(9267):1485-9. Epub 2001/05/30.
228. RCOG. Advice on preventing deep vein thrombosis for pregnant women travelling by air. Scientific Advisory Committee Opinion paper No 1. 2001;London RCOG.
229. Martinez L e. Travellers with special needs, International Travel and Health. Geneva: World Health Organization; 2002.
230. ACOG Committee Opinion No. 443: Air travel during pregnancy. Obstet Gynecol. 2009;114(4):954–5. Epub 2009/11/06.
231. Doyle P, Roman E, Beral V, Brookes M. Spontaneous abortion in dry cleaning workers potentially exposed to perchloroethylene. Occup Environ Med. 1997;54(12):848-53. Epub 1998/02/21.
232. Kolstad HA, Brandt LP, Rasmussen K. [Chlorinated solvents and fetal damage. Spontaneous abortions, low birth weight and malformations among women employed in the dry-cleaning industry]. Ugeskr Laeger. 1990;152(35):2481-2. Epub 1990/08/27. Klorerede oplosningsmidler og fosterskader. Spontane aborter, lav fodselsvaegt og misdannelser blandt kvinder beskaeftiget I kemiske tojrenserier.
233. Kyyronen P, Taskinen H, Lindbohm ML, Hemminki K, Heinonen OP. Spontaneous abortions and congenital malformations among women exposed to tetrachloroethylene in dry cleaning. J Epidemiol Community Health. 1989;43(4):346-51. Epub 1989/12/01.
234. Mozurkewich EL, Luke B, Avni M, Wolf FM. Working conditions and adverse pregnancy outcome: a meta-analysis. Obstet Gynecol. 2000;95(4):623-35. Epub 2000/03/22.
235. Hanke W, Kalinka J, Makowiec-Dabrowska T, Sobala W. Heavy physical work during pregnancy–a risk factor for small-for-gestational-age babies in Poland. Am J Ind Med. 1999;36(1):200-5. Epub 1999/06/11.
236. Bonzini M, Coggon D, Palmer KT. Risk of prematurity, low birthweight and pre-eclampsia in relation to working hours and physical activities: a systematic review. Occup Environ Med. 2007;64(4):228-43. Epub 2006/11/11.
237. Tanentsapf I, Heitmann BL, Adegboye AR. Systematic review of clinical trials on dietary interventions to prevent excessive weight gain during pregnancy among normal weight, overweight and obese women. BMC Pregnancy Childbirth. 2011;11:81. Epub 2011/10/28.
238. Imdad A, Bhutta ZA. Effect of balanced protein energy supplementation during pregnancy on birth outcomes. BMC Public Health. 2011;11 Suppl 3:S17. Epub 2011/04/29.
239. Streuling I, Beyerlein A, von Kries R. Can gestational weight gain be modified by increasing physical activity and diet counseling? A meta-analysis of interventional trials. Am J Clin Nutr. 2010;92(4):678-87. Epub 2010/07/30.
240. Kramer MS, Kakuma R. Energy and protein intake in pregnancy. Cochrane Database Syst Rev. 2010(4):CD000032. Epub 2003/10/30.
241. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2001(3):CD001056. Epub 2001/11/01.
242. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet. 1991;338(8760):131-7. Epub 1991/07/20.
243. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet.2001;358(9298):2069-73. Epub 2002/01/05.
244. Blencowe H, Cousens S, Modell B, Lawn J, Fall CH, Fisher DJ, et al. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol. 2010;39 Suppl 1:i110-21. Epub 2010/04/02 2010/02/04.
245. Hemminki E, Rimpela U. A randomized comparison of routine versus selective iron supplementation during pregnancy. J Am Coll Nutr. 1991;10(1):3-10. Epub 1991/02/01.
246. Pharmaceutical Society of Great B, British Medical A. British national formulary: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2003.
247. Pena-Rosas JP, Viteri FE. Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy. Cochrane Database Syst Rev. 2009(4):CD004736. Epub 2009/10/13.
248. Yakoob MY, Bhutta ZA. Effect of routine iron supplementation with or without folic acid on anemia during pregnancy. BMC Public Health. 2011;11 Suppl 3:S21. Epub 2011/04/29.
249. Brooke OG, Butters F, Wood C. Intrauterine vitamin D nutrition and postnatal growth in Asian infants. Br Med J (Clin Res Ed). 1981;283(6298):1024. Epub 1981/10/17.
250. Cockburn F, Belton NR, Purvis RJ, Giles MM, Brown JK, Turner TL, et al. Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J. 1980;281(6232):11-4. Epub 1980/07/05.
251. Datta S, Alfaham M, Davies DP, Dunstan F, Woodhead S, Evans J, et al. Vitamin D deficiency in pregnant women from a non-European ethnic minority population–an interventional study. BJOG. 2002;109(8):905-8. Epub 2002/08/29.
252. Mallet E, Gugi B, Brunelle P, Henocq A, Basuyau JP, Lemeur H. Vitamin D supplementation in pregnancy: a controlled trial of two methods. Obstet Gynecol. 1986;68(3):300-4. Epub 1986/09/01.
253. Delvin EE, Salle BL, Glorieux FH, Adeleine P, David LS. Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis. J Pediatr. 1986;109(2):328-34. Epub 1986/08/01.
254. De-Regil LM, Palacios C, Ansary A, Kulier R, Pena-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2012;2:CD008873. Epub 2012/02/18.
255. Buppasiri P, Lumbiganon P, Thinkhamrop J, Ngamjarus C, Laopaiboon M. Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes. Cochrane Database Syst Rev. 2011(10):CD007079. Epub 2011/10/07.
256. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010(8):CD001059. Epub 2010/08/06.
257. Imdad A, Jabeen A, Bhutta ZA. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries. BMC Public Health. 2011;11 Suppl 3:S18. Epub 2011/04/29.
258. Van DE, Kulier R, Gulmezoglu AM, Villar J. Vitamin A supplementation during pregnancy. Cochrane Database Syst Rev. 2002(4):CD001996. Epub 2003/01/10.
259. Ronsmans C, Fisher DJ, Osmond C, Margetts BM, Fall CH. Multiple micronutrientsupplementation during pregnancy in low-income countries: a meta-analysis of effects on stillbirths and on early and late neonatal mortality. Food Nutr Bull. 2009;30(4 Suppl):S547-55. Epub 2010/02/04.
260. Kawai K, Spiegelman D, Shankar AH, Fawzi WW. Maternal multiple micronutrient supplementation and pregnancy outcomes in developing countries: meta-analysis and metaregression. Bull World Health Organ. 2011;89(6):402-11B. Epub 2011/06/16.
261. Haider BA, Yakoob MY, Bhutta ZA. Effect of multiple micronutrient supplementation during pregnancy on maternal and birth outcomes. BMC Public Health. 2011;11 Suppl 3:S19. Epub 2011/04/29.
262. Shah PS, Ohlsson A. Effects of prenatal multimicronutrient supplementation on pregnancy outcomes: a meta-analysis. CMAJ. 2009;180(12):E99-108. Epub 2009/06/10.
263. Xiong X, Buekens P, Goldenberg RL, Offenbacher S, Qian X. Optimal timing of periodontal disease treatment for prevention of adverse pregnancy outcomes: before or during pregnancy? Am J Obstet Gynecol. 2011;205(2):111 e1-6. Epub 2011/05/31.
264. Polyzos NP, Polyzos IP, Zavos A, Valachis A, Mauri D, Papanikolaou EG, et al. Obstetric outcomes after treatment of periodontal disease during pregnancy: systematic review and metaanalysis. BMJ. 2010;341:c7017. Epub 2010/12/31.
265. Offenbacher S, Beck JD, Jared HL, Mauriello SM, Mendoza LC, Couper DJ, et al. Effects of periodontal therapy on rate of preterm delivery: a randomized controlled trial. Obstet Gynecol. 2009;114(3):551-9. Epub 2009/08/25.
266. Uppal A, Uppal S, Pinto A, Dutta M, Shrivatsa S, Dandolu V, et al. The effectiveness of periodontal disease treatment during pregnancy in reducing the risk of experiencing preterm birth and low birth weight: a meta-analysis. J Am Dent Assoc. 2010;141(12):1423-34. Epub 2010/12/02.
267. George A, Shamim S, Johnson M, Ajwani S, Bhole S, Blinkhorn A, et al. Periodontal treatment during pregnancy and birth outcomes: a meta-analysis of randomised trials. Int J Evid Based Healthc. 2011;9(2):122-47. Epub 2011/05/24.
268. Dyson L, McCormick F, Renfrew MJ. Interventions for promoting the initiation of breastfeeding. Cochrane Database Syst Rev. 2005(2):CD001688. Epub 2005/04/23.
269. Fairbank L, O’Meara S, Renfrew MJ, Woolridge M, Sowden AJ, Lister-Sharp D. A systematic review to evaluate the effectiveness of interventions to promote the initiation of breastfeeding. Health Technol Assess. 2000;4(25):1-171. Epub 2000/12/09.
270. Lavender T, Baker L, Smyth R, Collins S, Spofforth A, Dey P. Breastfeeding expectations versus reality: a cluster randomised controlled trial. BJOG. 2005;112(8):1047-53. Epub 2005/07/28.
271. Mattar CN, Chong YS, Chan YS, Chew A, Tan P, Chan YH, et al. Simple antenatal preparation to improve breastfeeding practice: a randomized controlled trial. Obstet Gynecol. 2007;109(1):73-80. Epub 2007/01/02.
272. Lumbiganon P, Martis R, Laopaiboon M, Festin MR, Ho JJ, Hakimi M. Antenatal breastfeeding education for increasing breastfeeding duration. Cochrane Database Syst Rev. 2012;11:CD006425. Epub 2011/11/11.
273. Little PJ. The incidence of urinary infection in 5000 pregnant women. Lancet.
1966;2(7470):925-8. Epub 1966/10/29.
274. Foley ME, Farquharson R, Stronge JM. Is screening for bacteriuria in pregnancy worthwhile? Br Med J (Clin Res Ed). 1987;295(6592):270. Epub 1987/07/25.
275. Leblanc AL, McGanity WJ. THE IMPACT OF BACTERIURIA IN PREGNANCY; A SURVEY OF 1300 PREGNANT PATIENTS. Tex Rep Biol Med. 1964;22:336-47. Epub 1964/01/01. 276. Kincaid-Smith P, Bullen M. BACTERIURIA IN PREGNANCY. Lancet. 1965;1(7382):395-9. Epub 1965/02/20.
277. Thomsen AC, Morup L, Hansen KB. Antibiotic elimination of group-B streptococci in urine in prevention of preterm labour. Lancet. 1987;1(8533):591-3. Epub 1987/03/14.
278. Elder HA, Santamarina BA, Smith S, Kass EH. The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. Am J Obstet Gynecol. 1971;111(3):441-62. Epub 1971/10/01.
279. Gold EM, Traub FB, Daichman I, Terris M. Asymptomatic bacteriuria during pregnancy. Obstet Gynecol. 1966;27(2):206-9. Epub 1966/02/01. 280. Mulla N. Bacteriuria in pregnancy. Obstet Gynecol. 1960;16:89-92. Epub 1960/07/01.
281. Savage WE, Hajj SN, Kass EH. Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine (Baltimore). 1967;46(5):385-407. Epub 1967/09/01.
282. Etherington IJ, James DK. Reagent strip testing of antenatal urine specimens for infection. Br J Obstet Gynaecol. 1993;100(9):806-8. Epub 1993/09/01.
283. Shelton SD, Boggess KA, Kirvan K, Sedor F, Herbert WN. Urinary interleukin-8 with asymptomatic bacteriuria in pregnancy. Obstet Gynecol. 2001;97(4):583-6. Epub 2001/03/29.
284. McNair RD, MacDonald SR, Dooley SL, Peterson LR. Evaluation of the centrifuged and Gram-stained smear, urinalysis, and reagent strip testing to detect asymptomatic bacteriuria in obstetric patients. Am J Obstet Gynecol. 2000;182(5):1076-9. Epub 2000/05/20.
285. Bachman JW, Heise RH, Naessens JM, Timmerman MG. A study of various tests to detect asymptomatic urinary tract infections in an obstetric population. JAMA. 1993;270(16):1971-4. Epub 1993/10/27.
286. Robertson AW, Duff P. The nitrite and leukocyte esterase tests for the evaluation of asymptomatic bacteriuria in obstetric patients. Obstet Gynecol. 1988;71(6 Pt 1):878-81. Epub 1988/06/01.
287. Tincello DG, Richmond DH. Evaluation of reagent strips in detecting asymptomatic bacteriuria in early pregnancy: prospective case series. BMJ. 1998;316(7129):435-7. Epub 1998/03/11.
288. Abyad A. Screening for asymptomatic bacteriuria in pregnancy: urinalysis vs urine culture. J Fam Pract. 1991;33(5):471-4. Epub 1991/11/01.
289. Mignini L, Carroli G, Abalos E, Widmer M, Amigot S, Nardin JM, et al. Accuracy of diagnostic tests to detect asymptomatic bacteriuria during pregnancy. Obstet Gynecol. 2009;113(2 Pt 1):346-52. Epub 2009/01/22.
290. Millar L, DeBuque L, Leialoha C, Grandinetti A, Killeen J. Rapid enzymatic urine screening test to detect bacteriuria in pregnancy. Obstet Gynecol. 2000;95(4):601-4. Epub 2000/03/22.
291. Villar J, Lydon-Rochelle MT, Gulmezoglu AM, Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev. 2000(2):CD000491. Epub 2000/05/05.
292. Smaill F, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2007(2):CD000490. Epub 2007/04/20.
293. Flynn CA, Helwig AL, Meurer LN. Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis. J Fam Pract. 1999;48(11):885-92. Epub 2000/07/25.
294. Gratacos E, Figueras F, Barranco M, Vila J, Cararach V, Alonso PL, et al. Spontaneous recovery of bacterial vaginosis during pregnancy is not associated with an improved perinatal outcome. Acta Obstet Gynecol Scand. 1998;77(1):37-40. Epub 1998/03/11.
295. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74(1):14-22. Epub 1983/01/01.
296. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29(2):297-301. Epub 1991/02/01.
297. Swadpanich U, Lumbiganon P, Prasertcharoensook W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev. 2008(2):CD006178. Epub 2008/04/22.
298. Nygren P, Fu R, Freeman M, Bougatsos C, Klebanoff M, Guise JM. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;148(3):220-33. Epub 2008/02/07.
299. Stamm WE, Harrison HR, Alexander ER, Cles LD, Spence MR, Quinn TC. Diagnosis of Chlamydia trachomatis infections by direct immunofluorescence staining of genital secretions. A multicenter trial. Ann Intern Med. 1984;101(5):638-41. Epub 1984/11/01.
300. Smith JW, Rogers RE, Katz BP, Brickler JF, Lineback PL, Van der Pol B, et al. Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics. J Clin Microbiol. 1987;25(5):868-72. Epub 1987/05/01.
301. Baselski VS, McNeeley SG, Ryan G, Robison M. A comparison of nonculture-dependent methods for detection of Chlamydia trachomatis infections in pregnant women. Obstet Gynecol. 1987;70(1):47-52. Epub 1987/07/01.
302. Garland SM, Tabrizi S, Hallo J, Chen S. Assessment of Chlamydia trachomatis prevalence by PCR and LCR in women presenting for termination of pregnancy. Sex Transm Infect. 2000;76(3):173-6. Epub 2000/08/29.
303. Andrews WW, Lee HH, Roden WJ, Mott CW. Detection of genitourinary tract Chlamydia trachomatis infection in pregnant women by ligase chain reaction assay. Obstet Gynecol. 1997;89(4):556-60. Epub 1997/04/01.
304. Thejls H, Gnarpe J, Gnarpe H, Larsson PG, Platz-Christensen JJ, Ostergaard L, et al. Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology. Genitourin Med. 1994;70(5):300-3. Epub 1994/10/01.
305. Macmillan S, McKenzie H, Templeton A. Parallel observation of four methods for screening women under 25 years of age for genital infection with Chlamydia trachomatis. Eur J Obstet Gynecol Reprod Biol. 2003;107(1):68-73. Epub 2003/02/21.
306. Renton A, Thomas BM, Gill S, Lowndes C, Taylor-Robinson D, Patterson K. Chlamydia trachomatis in cervical and vaginal swabs and urine specimens from women undergoing termination of pregnancy. Int J STD AIDS. 2006;17(7):443-7. Epub 2006/07/06.
307. Hosein IK, Kaunitz AM, Craft SJ. Detection of cervical Chlamydia trachomatis and Neisseria gonorrhoeae with deoxyribonucleic acid probe assays in obstetric patients. Am J Obstet Gynecol. 1992;167(3):588-91. Epub 1992/09/01.
308. Yang LI, Panke ES, Leist PA, Fry RJ, Lee RF. Detection of Chlamydia trachomatis endocervical infection in asymptomatic and symptomatic women: comparison of deoxyribonucleic acid probe test with tissue culture. Am J Obstet Gynecol. 1991;165(5 Pt 1):1444-53. Epub 1991/11/01.
309. Asbill KK, Higgins RV, Bahrani-Mostafavi Z, Vachris JC, Kotrotsios SH, Elliot MC, et al. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis colonization of the gravid cervix. Am J Obstet Gynecol. 2000;183(2):340-4; discussion 5-6. Epub 2000/08/15.
310. Spence MR, Barbacci M, Kappus E, Quinn T. A correlative study of Papanicolaou smear, fluorescent antibody, and culture for the diagnosis of Chlamydia trachomatis. Obstet Gynecol. 1986;68(5):691-5. Epub 1986/11/01.
311. Martin DH, Eschenbach DA, Cotch MF, Nugent RP, Rao AV, Klebanoff MA, et al. Double-Blind Placebo-Controlled Treatment Trial of Chlamydia trachomatis Endocervical Infections in Pregnant Women. Infect Dis Obstet Gynecol. 1997;5(1):10-7. Epub 1997/01/01.
312. Ryan GM, Jr., Abdella TN, McNeeley SG, Baselski VS, Drummond DE. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol. 1990;162(1):34-9. Epub 1990/01/01.
313. Rivlin ME, Morrison JC, Grossman JH, 3rd. Comparison of pregnancy outcome between treated and untreated women with chlamydial cervicitis. J Miss State Med Assoc. 1997;38(11):404-7. Epub 1997/11/19.
314. McMillan JA, Weiner LB, Lamberson HV, Hagen JH, Aubry RH, Abdul-Karim RW, et al. Efficacy of maternal screening and therapy in the prevention of chlamydia infection of the newborn. Infection. 1985;13(6):263-6. Epub 1985/11/01.
315. Preece PM, Tookey P, Ades A, Peckham CS. Congenital cytomegalovirus infection: predisposing maternal factors. J Epidemiol Community Health. 1986;40(3):205-9. Epub 1986/09/01.
316. Peckham CS, Chin KS, Coleman JC, Henderson K, Hurley R, Preece PM. Cytomegalovirus infection in pregnancy: preliminary findings from a prospective study. Lancet. 1983;1(8338):1352-5. Epub 1983/06/18.
317. Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchmann SD. Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1998;19(6):407-63. Epub 1998/07/21.
318. Stagno S, Whitley RJ. Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med. 1985;313(20):1270-4. Epub 1985/11/14.
319. Yinon Y, Farine D, Yudin MH. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstet Gynecol Surv. 2011;65(11):736-43. Epub 2011/03/08.
320. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331(18):1173-80. Epub 1994/11/03.
321. Chou R, Smits AK, Huffman LH, Fu R, Korthuis PT. Prenatal screening for HIV: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;143(1):38-54. Epub 2005/07/07.
322. Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla JL, Delfraissy JF, et al. PerinatalHIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA. 1998;280(1):55-60. Epub 1998/07/11.
323. CDC. Sexually transmitted diseases treatment guidelines 2002. Morbidity and Mortality Weekly Report. 2002;51:1–80.
324. Samson L, King S. Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada. CMAJ. 1998;158(11):1449-57. Epub 1998/06/18.
325. Van Doornum GJ, Buimer M, Gobbers E, Bindels PJ, Coutinho RA. Evaluation of an expanded two-ELISA approach for confirmation of reactive serum samples in an HIV-screening programme for pregnant women. J Med Virol. 1998;54(4):285-90. Epub 1998/04/29.
326. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep.59(RR-12):1-110. Epub 2010/12/17.
327. Tagbor H, Bruce J, Agbo M, Greenwood B, Chandramohan D. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomized controlled non-inferiority trial. PLoS One. 2011;5(12):e14425. Epub 2011/01/05.
328. Bardaji A, Sigauque B, Sanz S, Maixenchs M, Ordi J, Aponte JJ, et al. Impact of malaria atthe end of pregnancy on infant mortality and morbidity. J Infect Dis. 2011;203(5):691-9. Epub 2011/01/05.
329. Ishaque S, Yakoob MY, Imdad A, Goldenberg RL, Eisele TP, Bhutta ZA. Effectiveness of interventions to screen and manage infections during pregnancy on reducing stillbirths: a review. BMC Public Health. 2011;11 Suppl 3:S3. Epub 2011/04/29.
330. Ndibazza J, Muhangi L, Akishule D, Kiggundu M, Ameke C, Oweka J, et al. Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: a randomized controlled trial. Clin Infect Dis. 2010;50(4):531-40. Epub 2010/01/14.
331. Grangeot-Keros L, Enders G. Evaluation of a new enzyme immunoassay based on recombinant Rubella virus-like particles for detection of immunoglobulin M antibodies to Rubella virus. J Clin Microbiol. 1997;35(2):398-401. Epub 1997/02/01.
332. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2(8302):781-4. Epub 1982/10/09.
333. Grillner L, Forsgren M, Barr B, Bottiger M, Danielsson L, De Verdier C. Outcome of rubella during pregnancy with special reference to the 17th-24th weeks of gestation. Scand J Infect Dis. 1983;15(4):321-5. Epub 1983/01/01.
334. Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR–Morbidity and Mortality Weekly Report. 2001;50:1117.
335. Dontigny L, Arsenault MY, Martel MJ, Biringer A, Cormier J, Delaney M, et al. Rubella in pregnancy. J Obstet Gynaecol Can. 2008;30(2):152-68. Epub 2008/02/08.
336. STD Section HaSD, PHLS Communicable Disease Surveillance Centre, with the PHLS Syphilis Working Group. Report to the National Screening Committee. Antenatal Syphilis Screening in the UK: A Systematic Review and National Options Appraisal with Recommendations. London: PHLS; 1998.
337. Egglestone SI TA. Serological diagnosis of syphilis. Communicable Disease and Public Health/PHLS. 2000;3:158–62.
338. Blencowe H, Cousens S, Kamb M, Berman S, Lawn JE. Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health. 2011;11 Suppl 3:S9. Epub 2011/04/29.
339. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105(2):94-8. Epub 1977/02/01.
340. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2(8359):1099-102. Epub 1983/11/12.
341. Summers PR, Biswas MK, Pastorek JG, 2nd, Pernoll ML, Smith LG, Bean BE. The pregnant hepatitis B carrier: evidence favoring comprehensive antepartum screening. Obstet Gynecol. 1987;69(5):701-4. Epub 1987/05/01.
342. Chaita TM, Graham SM, Maxwell SM, Sirivasin W, Sabchareon A, Beeching NJ. Salivary sampling for hepatitis B surface antigen carriage: a sensitive technique suitable for epidemiological studies. Ann Trop Paediatr. 1995;15(2):135-9. Epub 1995/06/01.
343. Lin K, Vickery J. Screening for hepatitis B virus infection in pregnant women: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009;150(12):874-6. Epub 2009/06/17.
344. Yancey MK SA, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstetrics and Gynecology. 1996;88:811–5.
345. Boyer KM GC, Kelly PD, Burd LI, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. Journal of Infectious Diseases. 1983;148:802–9.
346. Schrag SJ ZE, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. New England Journal of Medicine. 2002;347:233–9.
347. Smaill F. Intrapartum antibiotics for group B streptococcal colonisation. Cochrane Database of Systematic Reviews. 1999;3:1–5.
348. Benitz WE GJ, Druzin ML. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics. 1999;103:e78.
349. Gibbs RS MF. Randomized clinical trial of intrapartum clindamycin cream for reduction of group B streptococcal maternal and neonatal colonization. Infectious Disease in Obstetrics and Gynecology. 1986;41:25–7.
350. Valkenburg-van den Berg AW, Houtman-Roelofsen RL, Oostvogel PM, Dekker FW, Dorr PJ, Sprij AJ. Timing of group B streptococcus screening in pregnancy: a systematic review. Gynecol Obstet Invest. 2010;69(3):174-83. Epub 2009/12/18.
351. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36. Epub 2010/11/23.
352. Centelles-Serrano MJ, Perez-Moreno MO, Llovet-Lombarte MI, Cortell-Ortola M, Jardi- Baiges AM, Buj-Gonzalez JI. [Effectiveness of systematic investigation for Group B Streptococcus in urine samples to identify colonized pregnant women]. Enferm Infecc Microbiol Clin.
2009;27(7):394-8. Epub 2009/05/02. Impacto de la investigacion sistematica de estreptococo del grupo B en orina en la identificacion de gestantes colonizadas.
353. Thangaratinam S, Gallos ID, Meah N, Usman S, Ismail KM, Khan KS. How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2011;90(6):564-73. Epub 2011/03/02.
354. Magann EF, Cummings JE, Niederhauser A, Rodriguez-Thompson D, McCormack R, Chauhan SP. Antepartum bleeding of unknown origin in the second half of pregnancy: a review. Obstet Gynecol Surv. 2005;60(11):741-5. Epub 2005/10/28.
355. Steer P, Alam MA, Wadsworth J, Welch A. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. BMJ. 1995;310(6978):489-91. Epub 1995/02/25.
356. Zhou LM, Yang WW, Hua JZ, Deng CQ, Tao X, Stoltzfus RJ. Relation of hemoglobin measured at different times in pregnancy to preterm birth and low birth weight in Shanghai, China. Am J Epidemiol. 1998;148(10):998-1006. Epub 1998/11/26.
357. Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad AH, Copper RL, et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health. 1998;88(2):233-8. Epub 1998/03/10.
358. Iams JD, Goldenberg RL, Mercer BM, Moawad AH, Meis PJ, Das AF, et al. The preterm prediction study: can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol. 2001;184(4):652-5. Epub 2001/03/23.
359. Kristensen J, Langhoff-Roos J, Kristensen FB. Implications of idiopathic preterm delivery for previous and subsequent pregnancies. Obstet Gynecol. 1995;86(5):800-4. Epub 1995/11/01.
360. Blondel B, Le Coutour X, Kaminski M, Chavigny C, Breart G, Sureau C. Prediction of preterm delivery: is it substantially improved by routine vaginal examinations? Am J Obstet Gynecol. 1990;162(4):1042-8. Epub 1990/04/01.
361. Chambers S, Pons JC, Richard A, Chiesa M, Bouyer J, Papiernik E. Vaginal infections, cervical ripening and preterm delivery. Eur J Obstet Gynecol Reprod Biol. 1991;38(2):103-8. Epub 1991/01/30.
362. Parikh MN, Mehta AC. Internal cervical os during the second half of pregnancy. J Obstet Gynaecol Br Emp. 1961;68:818-21. Epub 1961/10/01.
363. Leveno KJ, Cox K, Roark ML. Cervical dilatation and prematurity revisited. Obstet Gynecol. 1986;68(3):434-5. Epub 1986/09/01.
364. Alexander S, Boulvain M, Ceysens G, Haelterman E, Zhang WH. Repeat digital cervical assessment in pregnancy for identifying women at risk of preterm labour. Cochrane database of systematic reviews (Online). 2010;6:CD005940.
365. Heath VC, Daskalakis G, Zagaliki A, Carvalho M, Nicolaides KH. Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early preterm delivery. BJOG. 2000;107(10):1276-81. Epub 2000/10/12.
366. Chang TC, Chew TS, Pang M, Tan AC, Yeo GS. Cervicovaginal foetal fibronectin in the prediction of preterm labour in a low-risk population. Ann Acad Med Singapore. 1997;26(6):776-80. Epub 1998/04/02.
367. Faron G, Boulvain M, Lescrainier JP, Vokaer A. A single cervical fetal fibronectin screening test in a population at low risk for preterm delivery: an improvement on clinical indicators? Br J Obstet Gynaecol. 1997;104(6):697-701. Epub 1997/06/01.
368. Daskalakis G, Papapanagiotou A, Mesogitis S, Papantoniou N, Mavromatis K, Antsaklis A. Bacterial vaginosis and group B streptococcal colonization and preterm delivery in a low-risk population. Fetal Diagn Ther. 2006;21(2):172-6. Epub 2006/02/24.
369. Crane JM, Armson BA, Dodds L, Feinberg RF, Kennedy W, Kirkland SA. Risk scoring, fetal fibronectin, and bacterial vaginosis to predict preterm delivery. Obstet Gynecol. 1999;93(4):517-22. Epub 1999/04/24.
370. Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database of Systematic Reviews. 2008(4).
371. Honest H, Forbes CA, Duree KH, Norman G, Duffy SB, Tsourapas A, et al. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess. 2009;13(43):1-627. Epub 2009/10/03.
372. Inglis SR, Jeremias J, Kuno K, Lescale K, Peeper Q, Chervenak FA, et al. Detection of tumor necrosis factor-alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol. 1994;171(1):5-10. Epub 1994/07/01.
373. Lockwood CJ, Ghidini A, Wein R, Lapinski R, Casal D, Berkowitz RL. Increased interleukin-6 concentrations in cervical secretions are associated with preterm delivery. Am J Obstet Gynecol. 1994;171(4):1097-102. Epub 1994/10/01.
374. Goepfert AR, Goldenberg RL, Andrews WW, Hauth JC, Mercer B, Iams J, et al. The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 2001;184(3):483-8. Epub 2001/03/03.
375. Hvilsom GB, Thorsen P, Jeune B, Bakketeig LS. C-reactive protein: a serological marker for preterm delivery? Acta Obstet Gynecol Scand. 2002;81(5):424-9. Epub 2002/05/25.
376. Karinen L, Pouta A, Bloigu A, Koskela P, Paldanius M, Leinonen M, et al. Serum C-reactive protein and Chlamydia trachomatis antibodies in preterm delivery. Obstet Gynecol.
2005;106(1):73-80. Epub 2005/07/05.
377. Berghella V, Baxter JK, Hendrix NW. Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Database of Systematic Reviews. 2009(3).
378. Domin CM, Smith EJ, Terplan M. Transvaginal ultrasonographic measurement of cervical length as a predictor of preterm birth: a systematic review with meta-analysis. Ultrasound Q. 2010;26(4):241-8. Epub 2010/11/19.
379. Scott DA, Loveman E, McIntyre L, Waugh N. Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol Assess. 2002;6(11):1-161. Epub 2002/11/16.
380. Dornhorst A, Paterson CM, Nicholls JS, Wadsworth J, Chiu DC, Elkeles RS, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med. 1992;9(9):820-5. Epub 1992/11/01.
381. Davey RX, Hamblin PS. Selective versus universal screening for gestational diabetes mellitus: an evaluation of predictive risk factors. Med J Aust. 2001;174(3):118-21. Epub 2001/03/15.
382. Ostlund I, Hanson U. Occurrence of gestational diabetes mellitus and the value of different screening indicators for the oral glucose tolerance test. Acta Obstet Gynecol Scand. 2003;82(2):103-8. Epub 2003/03/22.
383. Kim C, Berger DK, Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care. 2007;30(5):1314-9. Epub 2007/02/10.
384. Watson W. Screening for glycosuria during pregnancy. Southern Medical Journal. 1990;83:156–8.
385. Gribble RK MP, Berg RL. The value of urine screening for glucose at each prenatal visit. Obstetrics and Gynecology. 1995;86:405–10.
386. Nasrat AA, Johnstone FD, Hasan SA. Is random plasma glucose an efficient screening test for abnormal glucose tolerance in pregnancy? Br J Obstet Gynaecol. 1988;95(9):855-60. Epub 1988/09/01.
387. Perucchini D FU, Spinas GA, Huch R, Huch A, Lehmann R. Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study. British Medical Journal. 1999;319:812–5.
388. Seshiah V, Balaji V, Balaji MS, Sanjeevi CB, Green A. Gestational diabetes mellitus in India. J Assoc Physicians India. 2004;52:707-11. Epub 2005/04/21.
389. Cetin M, Cetin A. Time-dependent gestational diabetes screening values. Int J Gynaecol Obstet. 1997;56(3):257-61. Epub 1997/03/01.
390. O’Sullivan JB, Mahan CM, Charles D, Dandrow RV. Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol. 1973;116(7):895-900. Epub 1973/08/01.
391. Reichelt AJ SE, Branchtein L, Nucci LB, Franco LJ, Schmidt M. Fasting plasma glucose is a useful test for the detection of gestational diabetes. Brazilian Study of Gestational Diabetes (EBDG) Working group. Diabetes Care. 1998;21:1246–9.
392. Fadl H, Ostlund I, Nilsson K, Hanson U. Fasting capillary glucose as a screening test for gestational diabetes mellitus. BJOG. 2006;113(9):1067-71. Epub 2006/09/08.
393. Griffin ME, Coffey M, Johnson H, Scanlon P, Foley M, Stronge J, et al. Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet Med. 2000;17(1):26-32. Epub 2000/02/26.
394. Rajab KE, Mehdi S. Pregnancy outcome among gestational diabetics with blood glucose levels between 7.7 and 8.3 mmol/l. Int J Gynaecol Obstet. 1998;63(1):59-61. Epub 1998/12/16.
395. Yogev Y, Langer O, Xenakis EM, Rosenn B. The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women. J Matern Fetal Neonatal Med. 2005;17(1):29-34. Epub 2005/04/05.
396. Dietrich ML, Dolnicek TF, Rayburn WF. Gestational diabetes screening in a private, midwestern American population. Am J Obstet Gynecol. 1987;156(6):1403-8. Epub 1987/06/01.
397. Sun B, Wang X, Song Q, Wang Y, Xue L, Wang C, et al. Prospective studies on the relationship between the 50 g glucose challenge test and pregnant outcome. Chin Med J (Engl). 1995;108(12):910-3. Epub 1995/12/01.
398. Schytte T, Jorgensen LG, Brandslund I, Petersen PH, Andersen B. The clinical impact of screening for gestational diabetes. Clin Chem Lab Med. 2004;42(9):1036-42. Epub 2004/10/23.
399. Weijers RN, Bekedam DJ, Goldschmidt HM, Smulders YM. The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus. Clin Chem Lab Med. 2006;44(1):99-104. Epub 2005/12/27.
400. Syed M, Javed H, Yakoob MY, Bhutta ZA. Effect of screening and management of diabetes during pregnancy on stillbirths. BMC Public Health. 2011;11 Suppl 3:S2. Epub 2011/04/29.
401. Hillier TA, Vesco KK, Pedula KL, Beil TL, Whitlock EP, Pettitt DJ. Screening for gestational diabetes mellitus: A systematic review for the U.S. preventive services task force. Annals of Internal Medicine. 2008;148(10):766-75.
402. Blatt AJ, Nakamoto JM, Kaufman HW. Gaps in diabetes screening during pregnancy and postpartum. Obstet Gynecol. 2011;117(1):61-8. Epub 2010/12/22.
403. Waugh N, Royle P, Clar C, Henderson R, Cummins E, Hadden D, et al. Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee. Health Technology Assessment. 2010;14(45):1-183. Epub 45.
404. Russell MA, Carpenter MW, Coustan DR. Screening and Diagnosis of Gestational Diabetes Mellitus. Clinical Obstetrics and Gynecology. 2007;50(4):949-58 10.1097/GRF.0b013e31815a5510.
405. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002. Epub 2008/05/09.
406. van Leeuwen M, Louwerse MD, Opmeer BC, Limpens J, Serlie MJ, Reitsma JB, et al. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review. BJOG. 2012;119(4):393-401. Epub 2012/01/21.
407. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders ofpregnancy. Am J Obstet Gynecol. 1988;158(4):892-8. Epub 1988/04/01.
408. National Collaborating Centre for Women’s and Children’s Health. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: NICE; 2010.
409. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1):IXXIV. Epub 2002/06/05. 410. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565. Epub 2005/03/04.
411. Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ. 2005;330(7491):576-80. Epub 2005/03/12.
412. Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess. 2008;12(6):iii-iv, 1-270. Epub 2008/03/12.
413. Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2008;198(1):7-22. Epub 2008/01/02.
414. Siqueira FM, Cota LO, Costa JE, Haddad JP, Lana AM, Costa FO. Maternal periodontitis as a potential risk variable for preeclampsia: a case-control study. J Periodontol. 2008;79(2):207-15. Epub 2008/02/07.
415. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev. 2007(2):CD004659. Epub
2007/04/20.
416. Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007(2):CD006490. Epub 2007/04/20.
417. Meher S, Duley L. Progesterone for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2006(4):CD006175. Epub 2006/10/21.
418. Churchill D, Beevers GD, Meher S, Rhodes C. Diuretics for preventing pre-eclampsia. Cochrane Database Syst Rev. 2007(1):CD004451. Epub 2007/01/27.
419. Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, et al. Low-molecularweight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension. 2005;45(1):86-91. Epub 2004/11/24.
420. Hofmeyr GJ, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2006(3):CD001059. Epub 2006/07/21.
421. Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev. 2008(1):CD004227. Epub 2008/02/07.
422. Wen SW, Chen XK, Rodger M, White RR, Yang Q, Smith GN, et al. Folic acid
supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol. 2008;198(1):45 e1-7. Epub 2008/01/02.
423. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor,
supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev. 2006(3):CD003402. Epub 2006/07/21.
424. Meher S, Duley L. Garlic for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2006(3):CD006065. Epub 2006/07/21.
425. Meher S, Duley L. Rest during pregnancy for preventing pre-eclampsia and its
complications in women with normal blood pressure. Cochrane Database Syst Rev. 2006(2):CD005939. Epub 2006/04/21.
426. Meher S, Duley L. Exercise or other physical activity for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2006(2):CD005942. Epub 2006/04/21.
427. Antartani R, Ashok K. Effect of lycopene in prevention of preeclampsia in high risk pregnant women. Journal of the Turkish German Gynecology Association. 2011;12(1):35-8. 428. Banerjee S, Jeyaseelan S, Guleria R. Trial of lycopene to prevent pre-eclampsia in healthy primigravidas: results show some adverse effects. J Obstet Gynaecol Res. 2009;35(3):477-82. Epub 2009/06/17.
429. Basaran A, Basaran M, Topatan B. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstet Gynecol Surv. 2010;65(10):653-67. Epub 2010/12/25.
430. Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC, Giguere Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2009;31(9):818-26. Epub 2009/11/28.
431. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a metaanalysis. Obstet Gynecol. 2009;116(2 Pt 1):402-14. Epub 2010/07/29.
432. Catov JM, Nohr EA, Bodnar LM, Knudson VK, Olsen SF, Olsen J. Association of periconceptional multivitamin use with reduced risk of preeclampsia among normal-weight women in the Danish National Birth Cohort. Am J Epidemiol. 2009;169(11):1304-11. Epub 2009/04/18.
433. Conde-Agudelo A, Romero R, Kusanovic JP, Hassan SS. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010;204(6):503 e1-12. Epub 2011/05/03.
434. Haugen M, Brantsaeter AL, Trogstad L, Alexander J, Roth C, Magnus P, et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology. 2009;20(5):720-6. Epub 2009/05/20.
435. Lambers MJ, Groeneveld E, Hoozemans DA, Schats R, Homburg R, Lambalk CB, et al. Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. Hum Reprod. 2009;24(10):2447-50. Epub 2009/07/18.
436. Lin JH, Yang YK, Liu H, Lin QD, Zhang WY. Effect of antioxidants on amelioration of high-risk factors inducing hypertensive disorders in pregnancy. Chin Med J (Engl). 2011;123(18):2548-54. Epub 2010/11/03.
437. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010;362(14):1282- 91. Epub 2010/04/09.
438. Teran E, Hernandez I, Nieto B, Tavara R, Ocampo JE, Calle A. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet. 2009;105(1):43-5. Epub 2009/01/22.
439. Waugh JJ, Clark TJ, Divakaran TG, Khan KS, Kilby MD. Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy. Obstet Gynecol. 2004;103(4):769-77. Epub 2004/03/31.
440. Gangaram R, Ojwang PJ, Moodley J, Maharaj D. The accuracy of urine dipsticks as a screening test for proteinuria in hypertensive disorders of pregnancy. Hypertens Pregnancy. 2005;24(2):117-23. Epub 2005/07/23.
441. Saikul S, Wiriyasirivaj B, Charoenchinont P. First 4-hour urinary protein – creatinine ratio for diagnosis of significant proteinuria in preeclampsia. J Med Assoc Thai. 2006;89 Suppl 4:S42-6. Epub 2007/08/30.
442. Rinehart BK, Terrone DA, Larmon JE, Perry KG, Jr., Martin RW, Martin JN, Jr. A 12-hour urine collection accurately assesses proteinuria in the hospitalized hypertensive gravida. J Perinatol. 1999;19(8 Pt 1):556-8. Epub 2000/01/25.
443. Waugh JJ, Bell SC, Kilby MD, Blackwell CN, Seed P, Shennan AH, et al. Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: a study of diagnostic accuracy. BJOG. 2005;112(4):412-7. Epub 2005/03/22.
444. Al RA, Baykal C, Karacay O, Geyik PO, Altun S, Dolen I. Random urine protein-creatinine ratio to predict proteinuria in new-onset mild hypertension in late pregnancy. Obstet Gynecol. 2004;104(2):367-71. Epub 2004/08/05.
445. Dwyer BK, Gorman M, Carroll IR, Druzin M. Urinalysis vs urine protein-creatinine ratio to predict significant proteinuria in pregnancy. J Perinatol. 2008;28(7):461-7. Epub 2008/02/22.
446. Leanos-Miranda A, Marquez-Acosta J, Romero-Arauz F, Cardenas-Mondragon GM, Rivera-Leanos R, Isordia-Salas I, et al. Protein:creatinine ratio in random urine samples is a reliable marker of increased 24-hour protein excretion in hospitalized women with hypertensive disorders of pregnancy. Clin Chem. 2007;53(9):1623-8. Epub 2007/07/31.
447. Ramos JG, Martins-Costa SH, Mathias MM, Guerin YL, Barros EG. Urinary
protein/creatinine ratio in hypertensive pregnant women. Hypertens Pregnancy. 1999;18(3):209- 18. Epub 1999/12/10.
448. Wheeler TL, 2nd, Blackhurst DW, Dellinger EH, Ramsey PS. Usage of spot urine protein to creatinine ratios in the evaluation of preeclampsia. Am J Obstet Gynecol. 2007;196(5):465 e1-4. Epub 2007/05/01.
449. Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, et al. Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol. 2008;199(3):268 e1-9. Epub 2008/09/06.
450. Jacobs M, Nassar N, Roberts CL, Hadfield R, Morris JM, Ashton AW. Levels of soluble fmslike tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review. Reprod Biol Endocrinol. 2011;9:77. Epub 2011/06/09.
451. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992-1005. Epub 2006/09/08.
452. Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, et al. Urinary placental growth factor and risk of preeclampsia. JAMA. 2005;293(1):77-85. Epub 2005/01/06.
453. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672-83. Epub 2004/02/07.
454. Lynch AM, Murphy JR, Gibbs RS, Levine RJ, Giclas PC, Salmon JE, et al. The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia. BJOG. 2010;117(4):456-62. Epub 2010/01/16.
455. Westergaard HB, Langhoff-Roos J, Lingman G, Marsal K, Kreiner S. A critical appraisal of the use of umbilical artery Doppler ultrasound in high-risk pregnancies: use of meta-analyses in evidence-based obstetrics. Ultrasound Obstet Gynecol. 2001;17(6):466-76. Epub 2001/06/26.
456. Williams KP, Farquharson DF, Bebbington M, Dansereau J, Galerneau F, Wilson RD, et al. Screening for fetal well-being in a high-risk pregnant population comparing the nonstress test with umbilical artery Doppler velocimetry: a randomized controlled clinical trial. Am J Obstet Gynecol. 2003;188(5):1366-71. Epub 2003/05/16.
457. Frusca T, Soregaroli M, Platto C, Enterri L, Lojacono A, Valcamonico A. Uterine artery velocimetry in patients with gestational hypertension. Obstet Gynecol. 2003;102(1):136-40. Epub 2003/07/10.
458. Ferrier C, North RA, Becker G, Cincotta R, Fairley K, Kincaid-Smith P. Uterine artery waveform as a predictor of pregnancy outcome in women with underlying renal disease. Clin Nephrol. 1994;42(6):362-8. Epub 1994/12/01.
459. Parretti E, Mealli F, Magrini A, Cioni R, Mecacci F, La Torre P, et al. Cross-sectional and longitudinal evaluation of uterine artery Doppler velocimetry for the prediction of pre-eclampsia in normotensive women with specific risk factors. Ultrasound Obstet Gynecol. 2003;22(2):160-5. Epub 2003/08/09.
460. Coleman MA, McCowan LM, North RA. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women. Ultrasound Obstet Gynecol. 2000;15(1):7-12. Epub 2000/04/25.
461. Caforio L, Testa AC, Mastromarino C, Carducci B, Ciampelli M, Mansueto D, et al. Predictive value of uterine artery velocimetry at midgestation in low- and high-risk populations: a new perspective. Fetal Diagn Ther. 1999;14(4):201-5. Epub 1999/07/27.
462. Asnafi N, Hajian K. Mid-trimester uterine artery Doppler ultrasound as a predictor of adverse obstetric outcome in high-risk pregnancy. Taiwan J Obstet Gynecol. 2011;50(1):29-32. Epub 2011/04/13.
463. Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, Schielen PC. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv. 2011;66(4):225-39. Epub 2011/07/16.
464. Alfirevic Z, Stampalija T, Gyte GM. Fetal and umbilical Doppler ultrasound in normal pregnancy. Cochrane Database Syst Rev. 2010(8):CD001450. Epub 2010/08/06.
465. Thangaratinam S, Coomarasamy A, O’Mahony F, Sharp S, Zamora J, Khan KS, et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med. 2009;7:10. Epub 2009/03/26.
466. Thangaratinam S, Ismail KM, Sharp S, Coomarasamy A, Khan KS. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG. 2006;113(4):369-78. Epub 2006/03/24.
467. Nisell H, Palm K, Wolff K. Prediction of maternal and fetal complications in preeclampsia. Acta Obstet Gynecol Scand. 2000;79(1):19-23. Epub 2000/01/26.
468. Menzies J, Magee LA, Macnab YC, Ansermino JM, Li J, Douglas MJ, et al. Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes. Hypertens Pregnancy. 2007;26(4):447-62. Epub 2007/12/11.
469. Thangaratinam S, Koopmans CM, Iyengar S, Zamora J, Ismail KM, Mol BW, et al. Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review. Acta Obstet Gynecol Scand. 2011;90(6):574-85. Epub 2011/03/02.
470. Elhassan EM, Mirghani OA, Habour AB, Adam I. Methyldopa versus no drug treatment in the management of mild pre-eclampsia. East Afr Med J. 2002;79(4):172-5. Epub 2003/03/11.
471. Montan S, Anandakumar C, Arulkumaran S, Ingemarsson I, Ratnam S. Randomised controlled trial of methyldopa and isradipine in preeclampsia–effects on uteroplacental and fetal hemodynamics. J Perinat Med. 1996;24(2):177-84. Epub 1996/01/01.
472. Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus
hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol. 1987;70(3 Pt 1):323-7. Epub 1987/09/01.
473. Sibai BM, Barton JR, Akl S, Sarinoglu C, Mercer BM. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol. 1992;167(4 Pt 1):879-84. Epub 1992/10/01.
474. Jabeen M, Yakoob MY, Imdad A, Bhutta ZA. Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths. BMC Public Health. 2011;11 Suppl 3:S6. Epub 2011/04/29.
475. Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010(11):CD000025. Epub 2010/11/12.
476. Duley L, Matar HE, Almerie MQ, Hall DR. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. Cochrane Database Syst Rev. 2010(8):CD007388. Epub 2010/08/06.
477. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks’ gestation: a randomized controlled trial. Am J Obstet Gynecol. 1994;171(3):818-22. Epub 1994/09/01.
478. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks’ gestation: a randomized controlled trial. Obstet Gynecol. 1990;76(6):1070-5. Epub 1990/12/01.
479. GRIT Study Group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG. 2003;110(1):27-32. Epub 2002/12/31.
480. Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet. 2004;364(9433):513-20. Epub 2004/08/11.
481. van Pampus MG, Wolf H, Westenberg SM, van der Post JA, Bonsel GJ, Treffers PE. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol. 1998;76(1):31-6. Epub 1998/03/03.
482. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443-51. Epub 2006/06/09.
483. Tabacova S, Little R, Tsong Y, Vega A, Kimmel CA. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf. 2003;12(8):633-46. Epub 2004/02/07.
484. Piper JM, Ray WA, Rosa FW. Pregnancy outcome following exposure to angiotensinconverting enzyme inhibitors. Obstet Gynecol. 1992;80(3 Pt 1):429-32. Epub 1992/09/01.
485. Lip GY, Churchill D, Beevers M, Auckett A, Beevers DG. Angiotensin-converting-enzyme inhibitors in early pregnancy. Lancet. 1997;350(9089):1446-7. Epub 1997/11/26.
486. Velazquez-Armenta EY, Han JY, Choi JS, Yang KM, Nava-Ocampo AA. Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature. Hypertens Pregnancy. 2007;26(1):51-66. Epub 2007/04/25.
487. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 1990;162(4):960-6; discussion 6-7. Epub 1990/04/01.
488. Weitz C, Khouzami V, Maxwell K, Johnson JW. Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. Int J Gynaecol Obstet. 1987;25(1):35-40. Epub 1987/02/01.
489. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ. 1990;301(6752):587-9. Epub 1990/09/22.
490. Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol. 1984;150(7):831-5. Epub 1984/12/01.
491. El Guindy AA, Nabhan AF. A randomized trial of tight vs. less tight control of mild essential and gestational hypertension in pregnancy. J Perinat Med. 2008;36(5):413-8. Epub 2008/07/09.
492. Magee LA, von Dadelszen P, Chan S, Gafni A, Gruslin A, Helewa M, et al. The Control of Hypertension In Pregnancy Study pilot trial. BJOG. 2007;114(6):770, e13-20. Epub 2007/05/23.
493. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355(9198):87-92. Epub 2000/02/16.
494. Nabhan AF, Elsedawy MM. Tight control of mild-moderate pre-existing or non-proteinuric gestational hypertension. Cochrane Database Syst Rev. 2011(7):CD006907. Epub 2011/07/08.
495. Paternoster DM, Stella A, Mussap M, Plebani M, Gambaro G, Grella PV. Predictive markers of pre-eclampsia in hypertensive disorders of pregnancy. Int J Gynaecol Obstet. 1999;66(3):237-43. Epub 1999/12/02.
496. Calvert SM, Tuffnell DJ, Haley J. Poor predictive value of platelet count, mean platelet volume and serum urate in hypertension in pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;64(2):179-84. Epub 1996/02/01.
497. Anumba DO, Lincoln K, Robson SC. Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension. Hypertens Pregnancy. 2010;29(2):163-79. Epub 2010/04/07.
498. Cruickshank DJ, Robertson AA, Campbell DM, MacGillivray I. Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study. Eur J Obstet Gynecol Reprod Biol. 1992;45(1):47-51. Epub 1992/06/16.
499. Pickles CJ, Broughton Pipkin F, Symonds EM. A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension. Br J Obstet Gynaecol. 1992;99(12):964-8. Epub 1992/12/01.
500. Pickles CJ, Symonds EM, Broughton Pipkin F. The fetal outcome in a randomized doubleblind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol. 1989;96(1):38-43. Epub 1989/01/01.
501. Rubin PC, Butters L, Clark DM, Reynolds B, Sumner DJ, Steedman D, et al. Placebocontrolled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet. 1983;1(8322):431-4. Epub 1983/02/26.
502. Plouin PF, Breart G, Llado J, Dalle M, Keller ME, Goujon H, et al. A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension. Br J Obstet Gynaecol. 1990;97(2):134-41. Epub 1990/02/01.
503. el-Qarmalawi AM, Morsy AH, al-Fadly A, Obeid A, Hashem M. Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension. Int J Gynaecol Obstet. 1995;49(2):125-30. Epub 1995/05/01.
504. Bharathi KN, Prasad KVSRG, Jagannath P, Nalini KS. A comparison of nifedipine with methyldopa for control of blood pressure in mild to moderate pregnancy induced hypertension. Journal of Clinical and Diagnostic Research. 2010;4(3):2406-9.
505. Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG. 2007;114(3):300-9. Epub 2006/12/15.
506. Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG. 2007;114(3):289-99. Epub 2006/12/15.
507. Duley L, Henderson-Smart DJ, Walker GJ, Chou D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev. 2010(12):CD000127. Epub 2010/12/15.
508. Duley L, Henderson-Smart DJ, Chou D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev. 2010(10):CD000128. Epub 2010/10/12.
509. Duley L, Gulmezoglu AM, Chou D. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst Rev. 2010(9):CD002960. Epub 2010/09/09.
510. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2006(3):CD001449. Epub 2006/07/21.
511. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955-60. Epub 2003/10/25.
512. Vigil-De Gracia P, Lasso M, Ruiz E, Vega-Malek JC, de Mena FT, Lopez JC. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2006;128(1-2):157-62. Epub 2006/04/20.
513. Vermillion ST, Scardo JA, Newman RB, Chauhan SP. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol. 1999;181(4):858-61. Epub 1999/10/16.
514. Hennessy A, Thornton CE, Makris A, Ogle RF, Henderson-Smart DJ, Gillin AG, et al. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial. Aust N Z J Obstet Gynaecol. 2007;47(4):279-85. Epub 2007/07/14.
515. Manzur-Verastegui S, Mandeville PB, Gordillo-Moscoso A, Hernandez-Sierra JF, Rodriguez-Martinez M. Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe preeclampsia: a randomized, triple-blind, controlled trial. Clin Exp Pharmacol Physiol. 2008;35(5-6):580-5. Epub 2007/12/12.
516. Raheem IA, Saaid R, Omar SZ, Tan PC. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG. 2011;119(1):78-85. Epub 2011/10/12.
517. Rep A, Ganzevoort W, Van Wassenaer AG, Bonsel GJ, Wolf H, De Vries JI. One-year infant outcome in women with early-onset hypertensive disorders of pregnancy. BJOG. 2008;115(2):290- 8. Epub 2007/11/01.
518. Visser W, van Pampus MG, Treffers PE, Wallenburg HC. Perinatal results of hemodynamic and conservative temporizing treatment in severe pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 1994;53(3):175-81. Epub 1994/03/15.
519. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006(3):CD004454. Epub 2006/07/21.
520. Tukur J, Umar NI, Khan N, Musa D. Comparison of emergency caesarean section to misoprostol induction for the delivery of antepartum eclamptic patients: a pilot study. Niger J Med. 2007;16(4):364-7. Epub 2007/12/18.
521. Alexander JM, Bloom SL, McIntire DD, Leveno KJ. Severe preeclampsia and the very low birth weight infant: is induction of labor harmful? Obstet Gynecol. 1999;93(4):485-8. Epub 1999/04/24.
522. Nassar AH, Adra AM, Chakhtoura N, Gomez-Marin O, Beydoun S. Severe preeclampsia remote from term: labor induction or elective cesarean delivery? Am J Obstet Gynecol. 1998;179(5):1210-3. Epub 1998/11/20.
523. Matchaba PT, Moodley J. WITHDRAWN: Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev. 2009(3):CD002076. Epub 2009/07/10.
524. Fonseca JE, Mendez F, Catano C, Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2005;193(5):1591-8. Epub 2005/11/02.
525. Isler CM, Magann EF, Rinehart BK, Terrone DA, Bass JD, Martin JN, Jr. Dexamethasone compared with betamethasone for glucocorticoid treatment of postpartum HELLP syndrome. Int J Gynaecol Obstet. 2003;80(3):291-7. Epub 2003/03/12.
526. Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev. 2010(9):CD008148. Epub 2010/09/09.
527. Pattinson RC, Norman K, Odendaal HJ. The role of Doppler velocimetry in the management of high risk pregnancies. Br J Obstet Gynaecol. 1994;101(2):114-20. Epub 1994/02/01.
528. Pattison N, McCowan L. WITHDRAWN. Cardiotocography for antepartum fetal assessment. Cochrane Database Syst Rev. 2010(1):CD001068. Epub 2010/01/22.
529. Lalor JG, Fawole B, Alfirevic Z, Devane D. Biophysical profile for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev. 2008(1):CD000038. Epub 2008/02/07.
530. DeFranco E AK, Heyl PS. Preterm Labor, Premature Rupture of Membranes, and Cervical Insufficiency. En: Evans, AT Manual of Obstetrics 7a ed Lippincott Williams & Wilkins. 2007:141-5.
531. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol.
2003;101(1):178-93. Epub 2003/01/09.
532. Amaya J GM. Ruptura prematura de membranas. In: Parra M, Angel E, editores Obstetricia Integral Siglo XXI Bogota: Universidad Nacional de Colombia. 2011:122-46.
533. Canavan TP, Simhan HN, Caritis S. An evidence-based approach to the evaluation and treatment of premature rupture of membranes: Part I. Obstet Gynecol Surv. 2004;59(9):669-77. Epub 2004/08/27.
534. Santolaya-Forgas J RR, Espinoza J, Erez O, Friel LA , Kusanovic JP,, al. B-SRe. Prelabor Rupture of the Membranes. in Clinical Obstetrics:
The Fetus & Mother 3a ed Blackwell Publishing. 2007:1130-88.
535. Lieman JM, Brumfield CG, Carlo W, Ramsey PS. Preterm premature rupture of membranes: is there an optimal gestational age for delivery? Obstet Gynecol. 2005;105(1):12-7. Epub 2004/12/31.
536. Friedman ML, McElin TW. Diagnosis of ruptured fetal membranes. Clinical study and review of the literature. Am J Obstet Gynecol. 1969;104(4):544-50. Epub 1969/06/15.
537. Lewis DF, Major CA, Towers CV, Asrat T, Harding JA, Garite TJ. Effects of digital vaginal examinations on latency period in preterm premature rupture of membranes. Obstet Gynecol. 1992;80(4):630-4. Epub 1992/10/01.
538. El-Messidi A, Cameron A. Diagnosis of premature rupture of membranes: inspiration from the past and insights for the future. J Obstet Gynaecol Can. 2010;32(6):561-9. Epub 2010/06/24.
539. Mulhair L, Carter J, Poston L, Seed P, Briley A. Prospective cohort study investigating the reliability of the AmnioSense method for detection of spontaneous rupture of membranes. BJOG. 2009;116(2):313-8. Epub 2008/07/26.
540. van der Ham DP, van Melick MJ, Smits L, Nijhuis JG, Weiner CP, van Beek JH, et al. Methods for the diagnosis of rupture of the fetal membranes in equivocal cases: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2011;157(2):123-7. Epub 2011/04/13.
541. Carroll SG, Papaioannou S, Ntumazah IL, Philpott-Howard J, Nicolaides KH. Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of the membranes. Br J Obstet Gynaecol. 1996;103(1):54-9. Epub 1996/01/01.
542. Yucel N, Yucel O, Yekeler H. The relationship between umbilical artery Doppler findings, fetal biophysical score and placental inflammation in cases of premature rupture of membranes. Acta Obstet Gynecol Scand. 1997;76(6):532-5. Epub 1997/07/01.
543. Vintzileos AM, Campbell WA, Nochimson DJ, Weinbaum PJ, Mirochnick MH, Escoto DT.
Fetal biophysical profile versus amniocentesis in predicting infection in preterm premature rupture of the membranes. Obstet Gynecol. 1986;68(4):488-94. Epub 1986/10/01.
544. Goldstein I, Romero R, Merrill S, Wan M, O’Connor TZ, Mazor M, et al. Fetal body and breathing movements as predictors of intraamniotic infection in preterm premature rupture of membranes. Am J Obstet Gynecol. 1988;159(2):363-8. Epub 1988/08/01.
545. Roussis P, Rosemond RL, Glass C, Boehm FH. Preterm premature rupture of membranes: detection of infection. Am J Obstet Gynecol. 1991;165(4 Pt 1):1099-104. Epub 1991/10/01.
546. Carroll SG, Papaioannou S, Nicolaides KH. Assessment of fetal activity and amniotic fluid volume in the prediction of intrauterine infection in preterm prelabor amniorrhexis. Am J Obstet Gynecol. 1995;172(5):1427-35. Epub 1995/05/01.
547. Carroll SG, Papaioannou S, Nicolaides KH. Doppler studies of the placental and fetal circulation in pregnancies with preterm prelabor amniorrhexis. Ultrasound Obstet Gynecol. 1995;5(3):184-8. Epub 1995/03/01.
548. Ismail MA, Zinaman MJ, Lowensohn RI, Moawad AH. The significance of C-reactive protein levels in women with premature rupture of membranes. Am J Obstet Gynecol. 1985;151(4):541-4. Epub 1985/02/15.
549. Ferguson MG, Rhodes PG, Morrison JC, Puckett CM. Clinical amniotic fluid infection and its effect on the neonate. Am J Obstet Gynecol. 1985;151(8):1058-61. Epub 1985/04/15.
550. van de Laar R, van der Ham DP, Oei SG, Willekes C, Weiner CP, Mol BW. Accuracy of Creactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2009;147(2):124-9. Epub 2009/10/13.
551. Popowski T, Goffinet F, Maillard F, Schmitz T, Leroy S, Kayem G. Maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study. BMC Pregnancy Childbirth. 2011;11:26. Epub 2011/04/08.
552. Wiwanitkit V. Maternal C-reactive protein for detection of chorioamnionitis: an appraisal. Infect Dis Obstet Gynecol. 2005;13(3):179-81. Epub 2005/08/30.
553. Trochez-Martinez RD, Smith P, Lamont RF. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. BJOG. 2007;114(7):796-801. Epub 2007/06/15.
554. Carroll SG, Ville Y, Greenough A, Gamsu H, Patel B, Philpott-Howard J, et al. Preterm prelabour amniorrhexis: intrauterine infection and interval between membrane rupture and delivery. Arch Dis Child Fetal Neonatal Ed. 1995;72(1):F43-6. Epub 1995/01/01.
555. Jacobsson B, Holst RM, Mattsby-Baltzer I, Nikolaitchouk N, Wennerholm UB, Hagberg H. Interleukin-18 in cervical mucus and amniotic fluid: relationship to microbial invasion of the amniotic fluid, intra-amniotic inflammation and preterm delivery. BJOG. 2003;110(6):598-603. Epub 2003/06/12.
556. Cotton DB, Gonik B, Bottoms SF. Conservative versus aggressive management of preterm rupture of membranes. A randomized trial of amniocentesis. Am J Perinatol. 1984;1(4):322-4. Epub 1984/07/01.
557. Porreco RP, Heyborne KD, Shapiro H. Amniocentesis in the management of preterm premature rupture of the membranes: a retrospective cohort analysis. J Matern Fetal Neonatal Med. 2008;21(8):573-9. Epub 2008/07/09.
558. Di Naro E GF, Raio L, Romano F, Mueller M, Mcdougall J, Cicinelli E. . C-reactive protein in vaginal fluid of patients with preterm premature rupture of membranes. Acta Obstet Gynecol Scand. 2003;82:1072–9.
559. Trochez-Martinez R SP, Lamont R. . Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. BJOG 2007;114:796–801.
560. Van de Laar R VdHD, Guid Oei b, Willekes C, Weiner P, Mol B. Accuracy of C-reactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2009;147(2):124-9.
561. Pettker M BI, Magloire L, Sfakianaki A, Hamar B, and Buhimschi, C. Value of Placental Microbial Evaluation in Diagnosing Intra-amniotic Infection. Obstet Gynecol. 2007;109:739–49.
562. Kim KW, Romero R, Park HS, Park CW, Shim SS, Jun JK, et al. A rapid matrix metalloproteinase-8 bedside test for the detection of intraamniotic inflammation in women with preterm premature rupture of membranes. Am J Obstet Gynecol. 2007;197(3):292 e1-5. Epub 2007/09/11.
563. Harding JE, Pang J, Knight DB, Liggins GC. Do antenatal corticosteroids help in the setting of preterm rupture of membranes? Am J Obstet Gynecol. 2001;184(2):131-9. Epub 2001/02/15.
564. Been JV, Degraeuwe PL, Kramer BW, Zimmermann LJ. Antenatal steroids and neonatal outcome after chorioamnionitis: a meta-analysis. BJOG. 2011;118(2):113-22. Epub 2010/11/09.
565. Vermillion ST, Bland ML, Soper DE. Effectiveness of a rescue dose of antenatal betamethasone after an initial single course. Am J Obstet Gynecol. 2001;185(5):1086-9. Epub 2001/11/22.
566. Crowther CA, McKinlay CJ, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2011(6):CD003935. Epub 2011/06/17.
567. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane. 2010(10).
568. Yudin MH, van Schalkwyk J, Van Eyk N, Boucher M, Castillo E, Cormier B, et al. Antibiotic therapy in preterm premature rupture of the membranes. J Obstet Gynaecol Can. 2009;31(9):863-7, 8-74. Epub 2009/11/28.
569. Flenady V, King JF. Antibiotics for prelabour rupture of membranes at or near term. Cochrane. 2011(2).
570. Shrivastava V, Ehsanipoor R, Lee RM, Chan K, Gaylean A, Garite T, et al. 165: Randomized double-blinded trial of indomethacin tocolysis versus expectant management in patients with premature rupture of membranes at 24-32 weeks of gestation. American Journal of Obstetrics and Gynecology. 2008;199(6):S59.
571. (RCOG) RCoOaG. Preterm prelabour rupture of membranes. 2006;Guideline; no. 44(Nov. 11). Epub London (UK).
572. Hopkins L, Smaill F. Antibiotic regimens for management of intraamniotic infection. Cochrane Database Syst Rev. 2002(3):CD003254. Epub 2002/07/26.
573. Locksmith GJ, Chin A, Vu T, Shattuck KE, Hankins GD. High compared with standard gentamicin dosing for chorioamnionitis: a comparison of maternal and fetal serum drug levels. Obstet Gynecol. 2005;105(3):473-9. Epub 2005/03/02.
574. Lyell DJ, Pullen K, Fuh K, Zamah AM, Caughey AB, Benitz W, et al. Daily compared with 8- hour gentamicin for the treatment of intrapartum chorioamnionitis: a randomized controlled trial. Obstet Gynecol. 2010;115(2 Pt 1):344-9. Epub 2010/01/23.
575. Fox NS, Saltzman DH, Roman AS, Klauser CK, Moshier E, Rebarber A. Intravaginal misoprostol versus Foley catheter for labour induction: a meta-analysis. BJOG. 2011;118(6):647- 54. Epub 2011/02/22.
576. Dare MR, Middleton P, Crowther CA, Flenady VJ, Varatharaju B. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst Rev. 2006(1):CD005302. Epub 2006/01/27.
577. Lin MG, Nuthalapaty FS, Carver AR, Case AS, Ramsey PS. Misoprostol for labor induction in
women with term premature rupture of membranes: a meta-analysis. Obstet Gynecol. 2005;106(3):593-601. Epub 2005/09/02.
578. Alfirevic Z, Weeks A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev. 2006(2):CD001338. Epub 2006/04/21.
579. Hofmeyr GJ, Gulmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. (10):CD000941. Epub 2010/10/12.
580. Hofmeyr GJ. Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour. Cochrane Database Syst Rev. 2010(2):CD000176.
581. Hofmeyr GJ. Amnioinfusion for umbilical cord compression in labour. Cochrane Database Syst Rev. 2012(2):CD000013. Epub 2000/05/05.
582. Hofmeyr GJ. Amnioinfusion for preterm rupture of membranes. Cochrane Database Syst Rev. 2011(2):CD000942. Epub 2000/05/05.
583. Pristauz G BM, Maurer-Fellbaum U, Rotky-Fast C, Bader A, Haas J,Lang U. . Neonatal outcome and two-year follow-up after expectant management of second trimester rupture of membranes. International Journal of Gynecology and Obstetrics. 2008;101:264–8.
584. Manuck T EA, Esplin S, Stoddard G, Varner M, and Silver R. Outcomes of Expectantly Managed Preterm Premature Rupture of Membranes Occurring Before 24 Weeks of Gestation. Obstet Gynecol. 2009;114:29–37.
585. Johanzon M OH, Jacobsson B, Sandberg K, and Wennerholm U. . Onset of Delivery and Its Effect on Infant Survival and Morbidity. Obstet Gynecol. 2008;111:42–50.
586. Melamed N B-HA, Pardo J, Chen R, Hadar E, Hod M, Yogev Y. . Expectant management of preterm premature rupture of membranes: is it all about gestational age? Am J Obstet Gynecol. 2011;204:48.e1-8.
587. Borna S BH, khazardoost S and Hantoushzadeh S. . Perinatal outcome in preterm premature rupture of membranes with Amniotic fluid index < 5 (AFI < 5). BMC Pregnancy and Childbirth. 2004:4:15.
588. Kayem G B-DA, Goffinet F, Cabrol D, Haddad B. . Active versus expectant management for preterm prelabor rupture of membranes at 34-36 weeks of completed gestation: comparison of maternal and neonatal outcomes. Acta Obstet Gynecol Scand. 2010;89(6):776-81.
589. Lieman J BC, Carlo W, Ramsey P. Preterm Premature Rupture of Membranes: Is There an Optimal Gestational Age for Delivery? Obstet Gynecol. 2005;105:12–7.
590. Javaid MK HS, Tahira T. Management pre labour rupture of the membranes at term; induction of labor compared with expectant. Professional Medical Journal. 2008;15(2).
591. Kayem G, Bernier-Dupreelle A, Goffinet F, Cabrol D, Haddad B. Active versus expectant management for preterm prelabor rupture of membranes at 34-36 weeks of completed gestation: comparison of maternal and neonatal outcomes. Acta Obstet Gynecol Scand. 2010;89(6):776-81. Epub 2010/03/17.
592. Canavan TP, Simhan HN, Caritis S. An evidence-based approach to the evaluation and treatment of premature rupture of membranes: Part II. Obstet Gynecol Surv. 2004;59(9):678-89. Epub 2004/08/27.
593. Mackeen AD, Seibel-Seamon J, Grimes-Dennis J, Baxter JK, Berghella V. Tocolytics for preterm premature rupture of membranes. Cochrane Database Syst Rev. 2011(10):CD007062. Epub 2011/10/07.
594. Neerhof MG, Cravello C, Haney EI, Silver RK. Timing of labor induction after premature rupture of membranes between 32 and 36 weeks’ gestation. Am J Obstet Gynecol. 1999;180(2 Pt 1):349-52. Epub 1999/02/13.
595. Buchanan SL, Crowther CA, Levett KM, Middleton P, Morris J. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks’ gestation for improving pregnancy outcome. Cochrane Database Syst Rev. 2010(3):CD004735. Epub 2010/03/20.
596. Gardner SE, Yow MD, Leeds LJ, Thompson PK, Mason EO, Jr., Clark DJ. Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol. 1979;135(8):1062-5. Epub 1979/12/15.
597. Wood EG, Dillon HC, Jr. A prospective study of group B streptococcal bacteriuria in pregnancy. Am J Obstet Gynecol. 1981;140(5):515-20. Epub 1981/07/01.
598. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002;347(4):240-7. Epub 2002/07/26.
599. de Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol. 1998;91(1):112-4. Epub 1998/02/17.
600. Lin FYC, Brenner RA, Johnson YR, Azimi PH, Philips Iii JB, Regan JA, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. American Journal of Obstetrics and Gynecology. 2001;184(6):1204-10.
601. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. 2009(3):CD007467. Epub 2009/07/10.
602. Stade B, Shah V, Ohlsson A. Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection. Cochrane Database Syst Rev. 2004(3):CD003520. Epub 2004/07/22.
603. Barber EL, Zhao G, Buhimschi IA, Illuzzi JL. Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery. Obstet Gynecol. 2008;112(2 Pt 1):265-70. Epub 2008/08/02.
604. Fiore Mitchell T, Pearlman MD, Chapman RL, Bhatt-Mehta V, Faix RG. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol. 2001;98(6):1075-9. Epub 2002/01/05.
605. Laiprasert J, Klein K, Mueller BA, Pearlman MD. Transplacental passage of vancomycin in noninfected term pregnant women. Obstet Gynecol. 2007;109(5):1105-10. Epub 2007/05/02.
606. Muller AE, Mouton JW, Oostvogel PM, Dorr PJ, Voskuyl RA, DeJongh J, et al.
Pharmacokinetics of clindamycin in pregnant women in the peripartum period. Antimicrob Agents Chemother. 2010;54(5):2175-81. Epub 2010/02/24.
607. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009(1):CD004661. Epub 2009/01/23.
608. Fan CK, Su KE, Chung WC, Tsai YJ, Chiol HY, Lin CF, et al. [Seroepidemiology of Toxoplasma gondii infection among Atayal aborigines and local animals in Nan-ao district, Ilan county and Jenai district, Nan-tou county, Taiwan]. Kaohsiung J Med Sci. 1998;14(12):762-9. Epub 1999/01/15.
609. Weigel RM DJ, Dyer D, Siegel AM. Risk factors for infection with Toxoplasma gondii for residents and workers on swine farms in Illinois. Am J Trop Med Hygiene. 1999;60:793–8.
610. Jeannel D NG, Costagliola D, Danis M, Traore BM, Gentilini M. Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol. 1988;17:595–602.
611. Afonso E TP, Gilot-Fromont E. . Local meteorological conditions, dynamics of
seroconversion to Toxoplasma gondii in cats (Felis catus) and oocyst burden in a rural environment. . :. Epidemiol Infect. 2010;138:1105–13.
612. Jenum PA KG, Stray-Pedersen B, Melby KK, Eskild A. Eng J. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect. 1998;120:87–92.
613. Chatterton JM. Ho-Yen DO JA, editors. Human toxoplasmosis. Oxford: Oxford Medical Publications. 1992:144–83.
614. Robert-Gangneux F, Gangneux JP, Vu N, Jaillard S, Guiguen C, Amiot L. High level of soluble HLA-G in amniotic fluid is correlated with congenital transmission of Toxoplasma gondii. Clin Immunol. 2011;138(2):129-34. Epub 2010/12/28.
615. Gomez-Marin J. Toxoplasma gondii, Brazil. Emerg Infect Dis. 2007;13(3):512; author reply – 3. Epub 2007/06/08.
616. Ljungstrom I GE, Nokes J, Linder E, Forsgren M. . Seroepidemiology of Toxoplasma gondii among pregnant women in different parts of Sweden. Eur J Epidemiol. 1995;11:149–56.
617. Jamieson SE, de Roubaix LA, Cortina-Borja M, Tan HK, Mui EJ, Cordell HJ, et al. Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One. 2008;3(6):e2285. Epub 2008/06/05.
618. Simpore J SA, Ilboudo D, Nadambega MC, Esposito M, Yara J, et al. . Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol. 2006;78:730–3.
619. Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol. 2010;26(4):190-6. Epub 2010/03/06.
620. Alvarado-Esquivel C, Liesenfeld O, Herrera-Flores RG, Ramirez-Sanchez BE, Gonzalez-Herrera A, Martinez-Garcia SA, et al. Seroprevalence of Toxoplasma gondii antibodies in cats from Durango City, Mexico. J Parasitol. 2007;93(5):1214-6. Epub 2008/01/01.
621. Cavalcante GT, Aguiar DM, Chiebao D, Dubey JP, Ruiz VL, Dias RA, et al. Seroprevalence of Toxoplasma gondii antibodies in cats and pigs from rural Western Amazon, Brazil. J Parasitol. 2006;92(4):863-4. Epub 2006/09/26.
622. Samad MA DB, Chowdhury NS, Akhtar S, Khan MR. . Sero-epidemiological studies on Toxoplasma gondii infection in man and animals in Bangladesh. Southeast Asian J Trop Med Public Health. 1997;28(2):339-43.
623. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000;321(7254):142-7. Epub 2000/07/14.
624. Boyer K, Hill D, Mui E, Wroblewski K, Karrison T, Dubey JP, et al. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis. 2011;53(11):1081-9. Epub 2011/10/25.
625. Lopez-Castillo CA, Diaz-Ramirez J, Gomez-Marin JE. [Risk factors for Toxoplasma gondii infection in pregnant women in Armenia, Colombia]. Rev Salud Publica (Bogota). 2005;7(2):180-90. Epub 2005/09/10. Factores de riesgo en mujeres embarazadas, infectadas por Toxoplasma gondii en Armenia- Colombia.
626. Lora F AH, Perez JE; Arias LE, Idarraga SE, Mier D, Gomez Marin JE. . Deteccion de Toxoplasma gondii en carnes de consumo humano por la tecnica de Reaccion en Cadena de la Polimerasa (PCR) en tres ciudades del eje cafetero. Infectio. 2007;11:117-23.
627. Villena I, Aubert D, Gomis P, Ferte H, Inglard JC, Denis-Bisiaux H, et al. Evaluation of a strategy for Toxoplasma gondii oocyst detection in water. Appl Environ Microbiol. 2004;70(7):4035-9. Epub 2004/07/09.
628. Breugelmans M, Naessens A, Foulon W. Prevention of toxoplasmosis during pregnancy – An epidemiologic survey over 22 consecutive years. Journal of Perinatal Medicine. 2004;32(3):211-4.
629. Pawlowski ZS, M. Gromadecka-Sutkiewicz, et al. Impact of health education on knowledge and prevention behavior for congenital toxoplasmosis: the experience in Poznan, Poland. . Health Educ Res. 2001;16(4):493-502.
630. Carter AO, Gelmon SB, Wells GA, Toepell AP. The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis. Epidemiol Infect. 1989;103(3):539-45. Epub 1989/12/01.
631. Nguyen Hoang Hanh D. Evolution des connaissances et des comportements au cours d’un programme d’education prenatale pour la prevention primaire de la toxoplasmose congenitale chez les femmes enceintes seronegatives pour la toxoplasmose. Region de Lyon, 1994-95. .
Bordeaux, Universite Victor Segalen Bordeaux 2: 62. 2004.
632. R Thiebaut SDC, R Gilbert, G Chene. T. Gondii Writing committee. Effect of the timing and type of prenatal treatment on clinical manifestations in children infected. SYROCOT Part II Unpublished. 2007.
633. Roberts A, Hedman K, Luyasu V, Zufferey J, Bessieres MH, Blatz RM, et al. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis. 2001;20(7):467-74. Epub 2001/09/20.
634. Gilbert R, Dunn D, Wallon M, Hayde M, Prusa A, Lebech M, et al. Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiol Infect. 2001;127(1):113-20. Epub 2001/09/20.
635. Nieto AJ GJ. Evaluacion basada en la evidencia de la medicion de anticuerpos IgG en la toxoplasmosis materna. Rev U Quindio. 2004;10:23-32.
636. Foulon W, Pinon JM, Stray-Pedersen B, Pollak A, Lappalainen M, Decoster A, et al. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol. 1999;181(4):843-7. Epub 1999/10/16.
637. Dupouy-Camet J, M. E. Bougnoux, et al. Comparative value of polymerase chain reaction and conventional biological tests for the prenatal diagnosis of congenital toxoplasmosis. Ann Biol Clin (Paris). 1992;50(5):315-9.
638. Fricker-Hidalgo H, Pelloux H, Muet F, Racinet C, Bost M, Goullier-Fleuret A, et al. Prenatal diagnosis of congenital toxoplasmosis: comparative value of fetal blood and amniotic fluid using serological techniques and cultures. Prenat Diagn. 1997;17(9):831-5. Epub 1997/10/08 22:25.
639. Robert-Gangneux F, Gavinet MF, Ancelle T, Raymond J, Tourte-Schaefer C, Dupouy-Camet J. Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J Clin Microbiol. 1999;37(9):2893-8. Epub 1999/08/17.
640. Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol. 2001;97(2):296-300. Epub 2001/02/13.
641. Thalib L, Gras L, Romand S, Prusa A, Bessieres MH, Petersen E, et al. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG. 2005;112(5):567-74. Epub 2005/04/22.
642. Briker L, J. Garcia, et al. . “Ultrasound screening in pregnancy: a systematic review of clinical Effectivness, cost-effectivness and women’s views.” Health Technol Assess. 2000;4(16):205.
643. Berrebi A, Kobuch WE, Bessieres MH, Bloom MC, Rolland M, Sarramon MF, et al. Termination of pregnancy for maternal toxoplasmosis. Lancet. 1994;344(8914):36-9. Epub 1994/07/02.
644. Pratlong F, Boulot P, Villena I, Issert E, Tamby I, Cazenave J, et al. Antenatal diagnosis of congenital toxoplasmosis: evaluation of the biological parameters in a cohort of 286 patients. Br J Obstet Gynaecol. 1996;103(6):552-7. Epub 1996/06/01.
645. Pinon JM, Dumon H, Chemla C, Franck J, Petersen E, Lebech M, et al. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol. 2001;39(6):2267-71. Epub 2001/05/29.
646. Tissot Dupont D, Fricker-Hidalgo H, Brenier-Pinchart MP, Bost-Bru C, Ambroise-Thomas P, Pelloux H. Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis. 2003;22(2):122-5. Epub 2003/03/11.
647. Naessens A, Jenum PA, Pollak A, Decoster A, Lappalainen M, Villena I, et al. Diagnosis of congenital toxoplasmosis in the neonatal period: A multicenter evaluation. J Pediatr. 1999;135(6):714-9. Epub 1999/12/10.
648. Wallon M, Dunn D, Slimani D, Girault V, Gay-Andrieu F, Peyron F. Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA? Eur J Pediatr. 1999;158(8):645-9. Epub 1999/08/13.
649. Rilling V, Dietz K, Krczal D, Knotek F, Enders G. Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis. 2003;22(3):174-80. Epub 2003/03/22.
650. Pinon JM, Chemla C, Villena I, Foudrinier F, Aubert D, Puygauthier-Toubas D, et al. Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol. 1996;34(3):579-83. Epub 1996/03/01.
651. Chumpitazi BF, Boussaid A, Pelloux H, Racinet C, Bost M, Goullier-Fleuret A. Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods. J Clin Microbiol. 1995;33(6):1479-85. Epub 1995/06/01.
652. Bessieres MH, Berrebi A, Rolland M, Bloom MC, Roques C, Cassaing S, et al. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur J Obstet Gynecol Reprod Biol. 2001;94(1):37-45. Epub 2001/01/03.
653. Gallego-Marin C, Henao AC, Gomez-Marin JE. Clinical validation of a western blot assay for congenital toxoplasmosis and newborn screening in a hospital in Armenia (Quindio) Colombia. J Trop Pediatr. 2006;52(2):107-12. Epub 2005/07/15.
654. Fricker-Hidalgo H, Brenier-Pinchart MP, Schaal JP, Equy V, Bost-Bru C, Pelloux H. Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J. 2007;26(9):845-6. Epub 2007/08/28.
655. Vasconcelos-Santos DV MAD, Campos WR, Orefice F, Queiroz-Andrade GM, Carellos EV, Castro Romanelli RM, Januario JN, Resende LM, Martins-Filho OA, de Aguiar Vasconcelos Carneiro AC, Almeida Vitor RW, Caiaffa WT. Congenital Toxoplasmosis Brazilian Group. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology. 2009;116(11):2199-205.
656. Lago EG BM, Hoefel Filho JR, Santiago D, Jungblut R. Agreement between ultrasonography and computed tomography in detecting intracranial calcifications in congenital toxoplasmosis. Clin Radiol. 2007;62(10):1004-11.
657. Faucher B G-MP, Franck J, Minodier P, Francois P, Gonnet S, L’ollivier C, Piarroux R. Longterm ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children. J Infect. 2012;64(1):104-9.
658. Berrebi A, Assouline C, Bessieres MH, Lathiere M, Cassaing S, Minville V, et al. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol. 2010;203(6):552 e1-6. Epub 2010/07/17.
659. Corvaisier S CB, Mounier C, Wallon M, Leboucher G, Al Kurdi M, Chaulet JF, Peyron F. Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis. Antimicrob Agents Chemother. 2004;48(10):3794-800.
660. Trenque T SN, Villena I, Chemla C, Quereux C, Leroux B, Jaussaud R, Remy G, Dupouy D, Millart H, Pinon JM, Urien S. . Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis. Br J Clin Pharmacol. 2004;57(6):735-41.
661. Umenai T, Wagner M, Page LA, Faundes A, Rattner D, Dias MA, et al. Conference agreement on the definition of humanization and humanized care. Int J Gynaecol Obstet. 2001;75 Suppl 1:S3-4. Epub 2001/12/18.
662. Page L. The humanization of birth. Int J Gynaecol Obstet. 2001;75 Suppl 1:S55-8. Epub 2001/12/18.
663. Uranga A. Guia para la atencion del Parto Normal en maternidades centradas en la familia. Argentina: Ministerio de salud de la Nacion Argentina; 2004.
664. MPS. Guia de atencion del parto. In: Ministerio de la Proteccion Social IdSP, Instituto de Investigaciones Clinicas. Universidad Nacional de Colombia., editor. Guias de promocion de la salud y prevencion de enfermedades en la salud publica. Bogota Colombia: Editorial Scripto Ltda; 2007.
665. NICE, NCWCH. Intrapartum care: care of healthy women and their babies during childbirth: RCOG Press; 2007.
666. Bailit JL, Dierker L, Blanchard MH, Mercer BM. Outcomes of women presenting in active versus latent phase of spontaneous labor. Obstet Gynecol. 2005;105(1):77-9. Epub 2004/12/31.
667. GPC. Guia de practica clinica sobre la atencion del parto normal. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Politica Social. 1.a, octubre 2010 ed: Agencia de Evaluacion de Tecnologias Sanitarias del Pais Vasco (OSTEBA). Agencia de Evaluacion de Tecnologias Sanitarias de Galicia (Avalia-t). Servicio Central de Publicaciones del Gobierno Vasco c/Donostia-San Sebastian, 1 – 01010 Vitoria-Gasteiz.; 2010.
668. [ICSI]. Management of labor. [Institute for Clinical Systems Improvement].
info@guidelinesgov (NGC). 2011.
669. Bix E, Reiner LM, Klovning A, Oian P. Prognostic value of the labour admission test and its effectiveness compared with auscultation only: a systematic review. BJOG. 2005;112(12):1595-604. Epub 2005/11/25.
670. Khunpradit S, Lumbiganon P, Laopaiboon M. Admission tests other than cardiotocography for fetal assessment during labour. Cochrane Database of Systematic Reviews. 2011(6).
671. Chauhan SP, Washburne JF, Magann EF, Perry KG, Jr., Martin JN, Jr., Morrison JC. A randomized study to assess the efficacy of the amniotic fluid index as a fetal admission test. Obstet Gynecol. 1995;86(1):9-13. Epub 1995/07/01.
672. Reveiz L, Gaitan H, Cuervo LG. Enemas during labour. Cochrane Database of Systematic Reviews. 2007(4).
673. Basevi V, Lavender T. Routine perineal shaving on admission in labour. Cochrane Database of Systematic Reviews. 2000(4).
674. Gross MM, Drobnic S, Keirse MJ. Influence of fixed and time-dependent factors on duration of normal first stage labor. Birth. 2005;32(1):27-33. Epub 2005/02/24.
675. Kilpatrick SJ, Laros RK, Jr. Characteristics of normal labor. Obstet Gynecol. 1989;74(1):85-7. Epub 1989/07/01.
676. Albers LL, Schiff M, Gorwoda JG. The length of active labor in normal pregnancies. Obstet Gynecol. 1996;87(3):355-9. Epub 1996/03/01.
677. Lavender T, Hart A, Walkinshaw S, Campbell E, Alfirevic Z. Progress of first stage of labour for multiparous women: an observational study. BJOG. 2005;112(12):1663-5. Epub 2005/11/25.
678. Albers LL. The duration of labor in healthy women. J Perinatol. 1999;19(2):114-9. Epub 2000/01/22.
679. Sprague AE, Oppenheimer L, McCabe L, Brownlee J, Graham ID, Davies B. The Ottawa Hospital’s Clinical Practice Guideline for the Second Stage of Labour. J Obstet Gynaecol Can. 2006;28(9):769-79. Epub 2006/10/07.
680. Zhang J, Landy HJ, Branch DW, Burkman R, Haberman S, Gregory KD, et al. Contemporary patterns of spontaneous labor with normal neonatal outcomes. Obstet Gynecol.
2010;116(6):1281-7. Epub 2010/11/26.
681. Neal JL, Lowe NK, Patrick TE, Cabbage LA, Corwin EJ. What is the slowest-yet-normal cervical dilation rate among nulliparous women with spontaneous labor onset? J Obstet Gynecol Neonatal Nurs. 2010;39(4):361-9. Epub 2010/07/16.
682. Lawrence A, Lewis L, Hofmeyr GJ, Dowswell T, Styles C. Maternal positions and mobility during first stage labour. Cochrane Database of Systematic Reviews. 2009(2).
683. Alfirevic Z, Devane D, Gyte GM. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev. 2006;3:CD006066. Epub 2006/07/21.
684. Mahomed K, Nyoni R, Mulambo T, Kasule J, Jacobus E. Randomised controlled trial of intrapartum fetal heart rate monitoring. BMJ. 1994;308(6927):497-500. Epub 1994/02/19.
685. Herbst A, Ingemarsson I. Intermittent versus continuous electronic monitoring in labour: a randomised study. Br J Obstet Gynaecol. 1994;101(8):663-8. Epub 1994/08/01.
686. Weber T. Cardiotocography supplemented with continuous fetal pH monitoring during labor. Effect on rate of obstetrical interventions and neonatal condition. Acta Obstet Gynecol Scand. 1982;61(4):351-5. Epub 1982/01/01.
687. Skupski DW, Eglinton GS. Intrapartum fetal stimulation tests: a meta-analysis. Obstet Gynecol. 2002;100(4):830. Epub 2002/10/18.
688. Su LL, Chong YS, Biswas A. Use of fetal electrocardiogram for intrapartum monitoring. Ann Acad Med Singapore. 2007;36(6):416-20. Epub 2007/06/29.
689. East Christine E, Begg L, Colditz Paul B. Fetal pulse oximetry for fetal assessment in labour. Cochrane Database of Systematic Reviews. 2007(2).
690. Neilson J. Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database of Systematic Reviews. 2006(3).
691. East Christine E, Leader Leo R, Sheehan P, Henshall Naomi E, Colditz Paul B. Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fetal heart rate trace. Cochrane Database of Systematic Reviews. 2010(3).
692. Pareja MV, Prieto AP, Badillo MPC, Herrezuelo IP, Ventoso FM. Comparison of the effectiveness of fetal pulse oximetry and fetal electrocardiogram in intrapartum risk of loss of fetal well-being. Progresos de Obstetricia y Ginecologia. 2010(4):141-7.
693. Hodnett ED, Gates S, Hofmeyr GJ, Sakala C. Continuous support for women during childbirth. Cochrane Database Syst Rev. 2003(3):CD003766. Epub 2003/08/15.
694. Hodnett ED, Gates S, Hofmeyr GJ, Sakala C. Continuous support for women during childbirth. Cochrane Database Syst Rev. 2007(3):CD003766. Epub 2007/07/20.
695. Hodnett ED, Gates S, Hofmeyr GJ, Sakala C, Weston J. Continuous support for women during childbirth. Cochrane Database of Systematic Reviews. 2010(2).
696. ASA. Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology. 2007;106(4):843- 63. Epub 2007/04/07.
697. Singata M, Tranmer J, Gyte Gillian ML. Restricting oral fluid and food intake during labour. Cochrane Database of Systematic Reviews. 2010(1).
698. O’Sullivan G, Liu B, Hart D, Seed P, Shennan A. Effect of food intake during labour on obstetric outcome: randomised controlled trial. BMJ. 2009;338:b784. Epub 2009/03/26.
699. Kubli M, Scrutton MJ, Seed PT, O’Sullivan G. An evaluation of isotonic “sport drinks” during labor. Anesth Analg. 2002;94(2):404-8, table of contents. Epub 2002/01/29.
700. Toohill J, Soong B, Flenady V. Interventions for ketosis during labour. Cochrane Database of Systematic Reviews. 2008(3).
701. Coco A, Derksen-Schrock A, Coco K, Raff T, Horst M, Hussar E. A randomized trial of increased intravenous hydration in labor when oral fluid is unrestricted. Fam Med. 2010;42(1):52-6. Epub 2010/01/12.
702. WHO. Care in Normal Birth: World Health Organization; 1996.
703. Seaward PG, Hannah ME, Myhr TL, Farine D, Ohlsson A, Wang EE, et al. International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. Am J Obstet Gynecol. 1997;177(5):1024-9. Epub 1997/12/16.
704. Hannah ME, Hodnett ED, Willan A, Foster GA, Di Cecco R, Helewa M. Prelabor rupture of the membranes at term: expectant management at home or in hospital? The TermPROM Study Group. Obstet Gynecol. 2000;96(4):533-8. Epub 2000/09/27.
705. Ezra Y, Michaelson-Cohen R, Abramov Y, Rojansky N. Prelabor rupture of the membranes at term: when to induce labor? Eur J Obstet Gynecol Reprod Biol. 2004;115(1):23-7. Epub 2004/06/30.
706. Seaward PG, Hannah ME, Myhr TL, Farine D, Ohlsson A, Wang EE, et al. International multicenter term PROM study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. Premature Rupture of the Membranes. Am J Obstet Gynecol. 1998;179(3 Pt 1):635-9. Epub 1998/10/03.
707. Lumbiganon P, Thinkhamrop J, Thinkhamrop B, Tolosa Jorge E. Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group B Streptococcal and HIV). Cochrane Database of Systematic Reviews. 2004(4).
708. WHO. World Health Organization partograph in management of labour. World Health Organization Maternal Health and Safe Motherhood Programme. Lancet. 1994;343(8910):1399-404. Epub 1994/06/04.
709. Lavender T, Hart A, Smyth Rebecca MD. Effect of partogram use on outcomes for women in spontaneous labour at term. Cochrane Database of Systematic Reviews. 2008(4).
710. Campillo F CM, Garcia-Hernandez JA, Miranda P, Romero F, Santamaria R. Indicadores de calidad asistencial en ginecologia y obstetricia. . Madrid: Fundacion Avedis Donabedian. Sociedad Espanola de Ginecologia y Obstetricia; 1999.
711. O’Sullivan G. Analgesia and anaesthesia in labour. Current Obstetrics and Gynaecology. 2005;15(1):9-17.
712. Pang D, O’Sullivan G. Analgesia and anaesthesia in labour. Obstetrics, Gynaecology and Reproductive Medicine. 2008;18(4):87-92.
713. ACOG. ACOG practice bulletin. Obstetric analgesia and anesthesia. Number 36, July 2002. American College of Obstetrics and Gynecology. Int J Gynaecol Obstet. 2002;78(3):321-35. Epub 2002/11/28.
714. Simkin PP, O’Hara M. Nonpharmacologic relief of pain during labor: systematic reviews of five methods. Am J Obstet Gynecol. 2002;186(5 Suppl Nature):S131-59. Epub 2002/05/16.
715. Huntley AL, Coon JT, Ernst E. Complementary and alternative medicine for labor pain: a systematic review. Am J Obstet Gynecol. 2004;191(1):36-44. Epub 2004/08/06.
716. Morgan-Ortiz F, Quintero-Ledezma JC, Perez-Sotelo JA, Trapero-Morales M. [Evolution and quality of care during labor and delivery in primiparous patients who underwent early obstetrical analgesia]. Ginecol Obstet Mex. 1999;67:522-6. Epub 2000/01/12. Evolucion y calidad de la atencion del trabajo de parto en pacientes primigestas sometidas a analgesia obstetrica temprana.
717. Cluett Elizabeth R, Burns E. Immersion in water in labour and birth. Cochrane Database of Systematic Reviews. 2009(2).
718. Smith Caroline A, Collins Carmel T, Crowther Caroline A. Aromatherapy for pain management in labour. Cochrane Database of Systematic Reviews. 2010(7).
719. Chao AS, Chao A, Wang TH, Chang YC, Peng HH, Chang SD, et al. Pain relief by applying transcutaneous electrical nerve stimulation (TENS) on acupuncture points during the first stage of labor: a randomized double-blind placebo-controlled trial. Pain. 2007;127(3):214-20. Epub 2006/10/13.
720. Carroll D, Tramer M, McQuay H, Nye B, Moore A. Transcutaneous electrical nerve stimulation in labour pain: a systematic review. Br J Obstet Gynaecol. 1997;104(2):169-75. Epub 1997/02/01.
721. Dowswell T, Bedwell C, Lavender T, Neilson JP. Transcutaneous electrical nerve stimulation (TENS) for pain relief in labour. Cochrane Database Syst Rev. 2009(2):CD007214. Epub 2009/04/17.
722. Ullman R, Smith LA, Burns E, Mori R, Dowswell T. Parenteral opioids for maternal pain relief in labour. Cochrane Database Syst Rev. 2011(9):CD007396. Epub 2010/09/09.
723. Arnal D, Serrano ML, Corral EM, Garcia del Valle S. [Intravenous remifentanyl for labor analgesia]. Rev Esp Anestesiol Reanim. 2009;56(4):222-31. Epub 2009/06/20. Remifentanilo intravenoso para analgesia del trabajo del parto.
724. Volmanen P, Sarvela J, Akural EI, Raudaskoski T, Korttila K, Alahuhta S. Intravenous remifentanil vs. epidural levobupivacaine with fentanyl for pain relief in early labour: a randomised, controlled, double-blinded study. Acta Anaesthesiol Scand. 2008;52(2):249-55. Epub 2007/11/17.
725. Wassen MM, Zuijlen J, Roumen FJ, Smits LJ, Marcus MA, Nijhuis JG. Early versus late epidural analgesia and risk of instrumental delivery in nulliparous women: a systematic review. BJOG. 2011;118(6):655-61. Epub 2011/03/12.
726. Anim-Somuah M, Smyth Rebecca MD, Jones L. Epidural versus non-epidural or no analgesia in labour. Cochrane Database of Systematic Reviews. 2011(12):CD000331.
727. Reynolds F, Sharma SK, Seed PT. Analgesia in labour and fetal acid-base balance: a metaanalysis comparing epidural with systemic opioid analgesia. BJOG. 2002;109(12):1344-53. Epub 2002/12/31.
728. Leighton BL, Halpern SH. The effects of epidural analgesia on labor, maternal, and neonatal outcomes: a systematic review. Am J Obstet Gynecol. 2002;186(5 Suppl Nature):S69-77. Epub 2002/05/16.
729. Simmons SW, Cyna AM, Dennis AT, Hughes D. Combined spinal-epidural versus epidural analgesia in labour. Cochrane Database Syst Rev. 2007(3):CD003401. Epub 2007/07/20.
730. [COMET]. Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a randomised controlled trial. Lancet. 2001;358(9275):19-23. Epub 2001/07/17.
731. Cammu H, Van Eeckhout E. A randomised controlled trial of early versus delayed use of amniotomy and oxytocin infusion in nulliparous labour. Br J Obstet Gynaecol. 1996;103(4):313-8. Epub 1996/04/01.
732. Lopez-Zeno JA, Peaceman AM, Adashek JA, Socol ML. A controlled trial of a program for the active management of labor. N Engl J Med. 1992;326(7):450-4. Epub 1992/02/13.
733. Smyth Rebecca MD, Alldred SK, Markham C. Amniotomy for shortening spontaneous labour. Cochrane Database of Systematic Reviews. 2007(4).
734. Brown Heather C, Paranjothy S, Dowswell T, Thomas J. Package of care for active management in labour for reducing caesarean section rates in low-risk women. Cochrane Database of Systematic Reviews. 2008(4).
735. Wei S, Wo Bi L, Xu H, Luo Z-C, Roy C, Fraser William D. Early amniotomy and early oxytocin for prevention of, or therapy for, delay in first stage spontaneous labour compared with routine care. Cochrane Database of Systematic Reviews. 2009(2).
736. Ruiz Parra AI. Nomenclatura Obstetrica, Trabajo de Parto y parto Eutocico. In: Parra MO, Angel Muller E, editors. Obstetricia Integral Siglo XXI. 1 ed. Bogota: Universidad Nacional de Colombia; 2010. p. 90-121.
737. Fescina RH. Salud sexual y reproductiva: guias para el continuo de atencion de la mujer y el recien nacido focalizadas en APS/ Sexual and reproductive health: guides for the HPC focused continuum of care of women and newborn. Montevideo, Uruguay: Montevideo; Centro Latinoamericano de Perinatologia, Salud de la Mujer y Reproductiva; 2011. p. 299.
738. Cheng YW, Hopkins LM, Caughey AB. How long is too long: Does a prolonged second stage of labor in nulliparous women affect maternal and neonatal outcomes? Am J Obstet Gynecol. 2004;191(3):933-8. Epub 2004/10/07.
739. Myles TD, Santolaya J. Maternal and neonatal outcomes in patients with a prolonged second stage of labor. Obstet Gynecol. 2003;102(1):52-8. Epub 2003/07/10.
740. Janni W, Schiessl B, Peschers U, Huber S, Strobl B, Hantschmann P, et al. The prognostic impact of a prolonged second stage of labor on maternal and fetal outcome. Acta Obstet Gynecol Scand. 2002;81(3):214-21. Epub 2002/04/23.
741. Menticoglou SM, Manning F, Harman C, Morrison I. Perinatal outcome in relation to second-stage duration. Am J Obstet Gynecol. 1995;173(3 Pt 1):906-12. Epub 1995/09/01.
742. Kuo YC, Chen CP, Wang KG. Factors influencing the prolonged second stage and the effects on perinatal and maternal outcomes. J Obstet Gynaecol Res. 1996;22(3):253-7. Epub 1996/06/01.
743. Paterson CM, Saunders NS, Wadsworth J. The characteristics of the second stage of labour in 25,069 singleton deliveries in the North West Thames Health Region, 1988. Br J Obstet Gynaecol. 1992;99(5):377-80. Epub 1992/05/01.
744. Saunders NS, Paterson CM, Wadsworth J. Neonatal and maternal morbidity in relation to the length of the second stage of labour. Br J Obstet Gynaecol. 1992;99(5):381-5. Epub 1992/05/01.
745. Van Kessel K, Reed S, Newton K, Meier A, Lentz G. The second stage of labor and stress urinary incontinence. Am J Obstet Gynecol. 2001;184(7):1571-5. Epub 2001/06/16.
746. Moon JM, Smith CV, Rayburn WF. Perinatal outcome after a prolonged second stage of labor. J Reprod Med. 1990;35(3):229-31. Epub 1990/03/01.
747. Mahon TR, Chazotte C, Cohen WR. Short labor: characteristics and outcome. Obstet Gynecol. 1994;84(1):47-51. Epub 1994/07/01.
748. Kjaergaard H, Olsen J, Ottesen B, Dykes AK. Incidence and outcomes of dystocia in the active phase of labor in term nulliparous women with spontaneous labor onset. Acta Obstet Gynecol Scand. 2008;88(4):402-7. Epub 2009/03/31.
749. Blanch G, Lavender T, Walkinshaw S, Alfirevic Z. Dysfunctional labour: a randomised trial. Br J Obstet Gynaecol. 1998;105(1):117-20. Epub 1998/01/27.
750. Wei SQ, Luo ZC, Xu H, Fraser WD. The effect of early oxytocin augmentation in labor: a meta-analysis (Structured abstract). Obstetrics and gynecology. 2009(3):641-9.
751. Mori R, Tokumasu H, Pledge D, Kenyon S. High dose versus low dose oxytocin for augmentation of delayed labour. Cochrane Database of Systematic Reviews. 2011(10).
752. Bugg GJ, Siddiqui F, Thornton Jim G. Oxytocin versus no treatment or delayed treatment for slow progress in the first stage of spontaneous labour. Cochrane Database of Systematic Reviews. 2011(7).
753. Pattinson RC, Farrell El-Marie E. Pelvimetry for fetal cephalic presentations at or near term. Cochrane Database of Systematic Reviews. 1997(2).
754. Dujardin B, Van Cutsem R, Lambrechts T. The value of maternal height as a risk factor of dystocia: A meta-analysis. Tropical Medicine and International Health. 1996;1(4):510-21.
755. Chauhan SP, Grobman WA, Gherman RA, Chauhan VB, Chang G, Magann EF, et al. Suspicion and treatment of the macrosomic fetus: A review. American journal of obstetrics and gynecology. 2005;193(2):332-46.
756. Darmstadt GL, Yakoob MY, Haws RA, Menezes EV, Soomro T, Bhutta ZA. Reducing stillbirths: interventions during labour. BMC Pregnancy Childbirth. 2009;9 Suppl 1:S6. Epub 2009/05/14.
757. Andrews V, Sultan AH, Thakar R, Jones PW. Risk factors for obstetric anal sphincter injury: a prospective study. Birth. 2006;33(2):117-22. Epub 2006/05/31.
758. Andrews CM, Chrzanowski M. Maternal position, labor, and comfort. Appl Nurs Res. 1990;3(1):7-13. Epub 1990/02/01.
759. Bloom SL, McIntire DD, Kelly MA, Beimer HL, Burpo RH, Garcia MA, et al. Lack of effect of walking on labor and delivery. N Engl J Med. 1998;339(2):76-9. Epub 1998/07/09.
760. Souza JP, Miquelutti MA, Cecatti JG, Makuch MY. Maternal position during the first stage of labor: a systematic review. Reprod Health. 2006;3:10. Epub 2006/12/02.
761. Roberts CL, Algert CS, Olive E. Impact of first-stage ambulation on mode of delivery among women with epidural analgesia. Aust N Z J Obstet Gynaecol. 2004;44(6):489-94. Epub 2004/12/16.
762. Stremler R, Hodnett E, Petryshen P, Stevens B, Weston J, Willan AR. Randomized controlled trial of hands-and-knees positioning for occipitoposterior position in labor. Birth. 2005;32(4):243-51. Epub 2005/12/13.
763. Ragnar I, Altman D, Tyden T, Olsson SE. Comparison of the maternal experience and duration of labour in two upright delivery positions–a randomised controlled trial. BJOG. 2006;113(2):165-70. Epub 2006/01/18.
764. Roberts CL, Algert CS, Cameron CA, Torvaldsen S. A meta-analysis of upright positions in the second stage to reduce instrumental deliveries in women with epidural analgesia. Acta Obstet Gynecol Scand. 2005;84(8):794-8. Epub 2005/07/20.
765. Gupta JK, Hofmeyr GJ, Shehmar M. Position in the second stage of labour for women without epidural anaesthesia. Cochrane Database Syst Rev. 2012;5:CD002006. Epub 2012/05/18.
766. Dupuis O, Simon A. [Fetal monitoring during the active second stage of labor]. J Gynecol Obstet Biol Reprod (Paris). 2008;37 Suppl 1:S93-100. Epub 2008/01/22. La surveillance foetale pendant l’expulsion.
767. Stamp G, Kruzins G, Crowther C. Perineal massage in labour and prevention of perineal trauma: randomised controlled trial. BMJ. 2001;322(7297):1277-80. Epub 2001/05/26.
768. Dahlen HG, Homer CS, Cooke M, Upton AM, Nunn R, Brodrick B. Perineal outcomes and maternal comfort related to the application of perineal warm packs in the second stage of labor: a randomized controlled trial. Birth. 2007;34(4):282-90. Epub 2007/11/21.
769. McCandlish R, Bowler U, van Asten H, Berridge G, Winter C, Sames L, et al. A randomized controlled trial of care of the perineum during second stage of normal labour. Br J Obstet Gynaecol. 1998;105(12):1262-72. Epub 1999/01/12.
770. Laine K, Pirhonen T, Rolland R, Pirhonen J. Decreasing the incidence of anal sphincter tears during delivery. Obstet Gynecol. 2008;111(5):1053-7. Epub 2008/05/02.
771. Sanders J, Campbell R, Peters TJ. Effectiveness and acceptability of lidocaine spray in reducing perineal pain during spontaneous vaginal delivery: randomised controlled trial. BMJ. 2006;333(7559):117. Epub 2006/06/30.
772. Schaffer JI, Bloom SL, Casey BM, McIntire DD, Nihira MA, Leveno KJ. A randomized trial of the effects of coached vs uncoached maternal pushing during the second stage of labor on postpartum pelvic floor structure and function. Am J Obstet Gynecol. 2005;192(5):1692-6. Epub 2005/05/20.
773. Brancato RM, Church S, Stone PW. A meta-analysis of passive descent versus immediate pushing in nulliparous women with epidural analgesia in the second stage of labor. J Obstet Gynecol Neonatal Nurs. 2008;37(1):4-12. Epub 2008/01/30.
774. Roberts CL, Torvaldsen S, Cameron CA, Olive E. Delayed versus early pushing in women with epidural analgesia: a systematic review and meta-analysis. BJOG. 2004;111(12):1333-40. Epub 2005/01/25.
775. Kelly M, Johnson E, Lee V, Massey L, Purser D, Ring K, et al. Delayed versus immediate pushing in second stage of labor. MCN Am J Matern Child Nurs. 2010;35(2):81-8. Epub 2010/03/11.
776. Gillesby E, Burns S, Dempsey A, Kirby S, Mogensen K, Naylor K, et al. Comparison of delayed versus immediate pushing during second stage of labor for nulliparous women with epidural anesthesia. Journal of obstetric, gynecologic, and neonatal nursing : JOGNN / NAACOG. 2010(6):635-44.
777. Hartmann K, Viswanathan M, Palmieri R, Gartlehner G, Thorp J, Jr., Lohr KN. Outcomes of routine episiotomy: a systematic review. JAMA. 2005;293(17):2141-8. Epub 2005/05/05.
778. Carroli G, Mignini L. Episiotomy for vaginal birth. Cochrane Database of Systematic Reviews. 2009(1).
779. Dannecker C, Hillemanns P, Strauss A, Hasbargen U, Hepp H, Anthuber C. Episiotomy and perineal tears presumed to be imminent: randomized controlled trial. Acta Obstet Gynecol Scand. 2004;83(4):364-8. Epub 2004/03/10.
780. Murphy DJ, Macleod M, Bahl R, Goyder K, Howarth L, Strachan B. A randomised controlled trial of routine versus restrictive use of episiotomy at operative vaginal delivery: a multicenter pilot study. BJOG. 2008;115(13):1695-702; discussion 702-3. Epub 2008/11/28.
781. Sangalli MR, Floris L, Faltin D, Weil A. Anal incontinence in women with third or fourth degree perineal tears and subsequent vaginal deliveries. Aust N Z J Obstet Gynaecol. 2000;40(3):244-8. Epub 2000/11/07.
782. Dandolu V, Gaughan JP, Chatwani AJ, Harmanli O, Mabine B, Hernandez E. Risk of recurrence of anal sphincter lacerations. Obstet Gynecol. 2005;105(4):831-5. Epub 2005/04/02.
783. Harkin R, Fitzpatrick M, O’Connell PR, O’Herlihy C. Anal sphincter disruption at vaginal delivery: is recurrence predictable? Eur J Obstet Gynecol Reprod Biol. 2003;109(2):149-52. Epub 2003/07/16.
784. Verheijen Evelyn C, Raven Joanna H, Hofmeyr GJ. Fundal pressure during the second stage of labour. Cochrane Database of Systematic Reviews. 2009(4).
785. Api O, Balcin ME, Ugurel V, Api M, Turan C, Unal O. The effect of uterine fundal pressure on the duration of the second stage of labor: a randomized controlled trial. Acta obstetricia et gynecologica Scandinavica. 2009(3):320-4.
786. Kang JH, Lee GH, Park YB, Jun HS, Lee KJ, Hahn WB, et al. The efficacy and safety of inflatable obstetric belts for management of the second stage of labor. Journal of Korean medical science. 2009(5):951-5.
787. Kettle C, Hills RK, Ismail KM. Continuous versus interrupted sutures for repair of episiotomy or second degree tears. Cochrane Database Syst Rev. 2007(4):CD000947. Epub 2007/10/19.
788. Kettle C, Dowswell T, Ismail Khaled MK. Absorbable suture materials for primary repair of episiotomy and second degree tears. Cochrane Database of Systematic Reviews. 2010(6).
789. Mota R, Costa F, Amaral A, Oliveira F, Santos CC, Ayres-De-Campos D. Skin adhesive versus subcuticular suture for perineal skin repair after episiotomy–a randomized controlled trial. Acta obstetricia et gynecologica Scandinavica. 2009(6):660-6.
790. McDonald SJ, Middleton P. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database of Systematic Reviews. 2008(2).
791. Hutton EK, Hassan ES. Late vs early clamping of the umbilical cord in full-term neonates: systematic review and meta-analysis of controlled trials. JAMA. 2007;297(11):1241-52. Epub 2007/03/22.
792. Mathew JL. Timing of umbilical cord clamping in term and preterm deliveries and infant and maternal outcomes: a systematic review of randomized controlled trials. Indian Pediatr. 2011;48(2):123-9. Epub 2011/03/08.
793. Jahazi A, Kordi M, Mirbehbahani NB, Mazloom SR. The effect of early and late umbilical cord clamping on neonatal hematocrit. J Perinatol. 2008;28(8):523-5. Epub 2008/07/04.
794. Ceriani Cernadas JM, Carroli G, Pellegrini L, Ferreira M, Ricci C, Casas O, et al. [The effect of early and delayed umbilical cord clamping on ferritin levels in term infants at six months of life: a randomized, controlled trial]. Arch Argent Pediatr. 2010;108(3):201-8. Epub 2010/06/15. Efecto del clampeo demorado del cordon umbilical en la ferritina serica a los seis meses de vida: Estudio clinico controlado aleatorizado.
795. Moore ER, Anderson GC, Bergman N. Early skin-to-skin contact for mothers and their healthy newborn infants. Cochrane Database Syst Rev. 2007(3):CD003519. Epub 2007/07/20.
796. Mori R, Khanna R, Pledge D, Nakayama T. Meta-analysis of physiological effects of skin-toskin contact for newborns and mothers. Pediatr Int. 2010;52(2):161-70. Epub 2009/06/13.
797. Kulier R, Hofmeyr GJ. Tocolytics for suspected intrapartum fetal distress. Cochrane Database of Systematic Reviews. 1998(2).
798. Hofmeyr GJ, Kulier R. Tocolysis for preventing fetal distress in second stage of labour. Cochrane Database of Systematic Reviews. 2011(1).
799. O’Mahony F, Hofmeyr GJ, Menon V. Choice of instruments for assisted vaginal delivery. Cochrane Database of Systematic Reviews. 2010(11).
800. Suwannachat B, Lumbiganon P, Laopaiboon M. Rapid versus stepwise negative pressure application for vacuum extraction assisted vaginal delivery. Cochrane Database of Systematic Reviews. 2008(3).
801. Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Antibiotic prophylaxis for operative vaginal delivery. Cochrane Database of Systematic Reviews. 2004(3).
802. Gherman RB, Chauhan S, Ouzounian JG, Lerner H, Gonik B, Goodwin TM. Shoulder dystocia: The unpreventable obstetric emergency with empiric management guidelines. American journal of obstetrics and gynecology. 2006;195(3):657-72.
803. Spong CY, Beall M, Rodrigues D, Ross MG. An objective definition of shoulder dystocia: prolonged head-to-body delivery intervals and/or the use of ancillary obstetric maneuvers. Obstet Gynecol. 1995;86(3):433-6. Epub 1995/09/01.
804. Beall MH, Spong C, McKay J, Ross MG. Objective definition of shoulder dystocia: a prospective evaluation. Am J Obstet Gynecol. 1998;179(4):934-7. Epub 1998/10/28.
805. Athukorala C, Middleton P, Crowther Caroline A. Intrapartum interventions for preventing shoulder dystocia. Cochrane Database of Systematic Reviews. 2006(4).
806. Hoffman MK, Bailit JL, Branch DW, Burkman RT, Van Veldhusien P, Lu L, et al. A comparison of obstetric maneuvers for the acute management of shoulder dystocia. Obstetrics and gynecology. 2011;117(6):1272-8.
807. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev. 2000(3):CD000007. Epub 2000/07/25.
808. Begley CM, Gyte GM, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2011(11):CD007412. Epub 2011/11/11.
809. Elbourne DR, Prendiville WJ, Carroli G, Wood J, McDonald S. Prophylactic use of oxytocin in the third stage of labour. Cochrane Database Syst Rev. 2001(4):CD001808. Epub 2001/11/01.
810. Soltani H, Hutchon DR, Poulose TA. Timing of prophylactic uterotonics for the third stage of labour after vaginal birth. Cochrane Database Syst Rev. 2010(8):CD006173. Epub 2010/08/06.
811. McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2004(1):CD000201. Epub 2004/02/20.
812. Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2007(3):CD000494. Epub 2007/07/20.
813. Alfirevic Z, Blum J, Walraven G, Weeks A, Winikoff B. Prevention of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet. 2007;99 Suppl 2:S198-201. Epub 2007/10/27.
814. Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database Syst Rev. 2007(2):CD005456. Epub 2007/04/20.
815. Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2010(7):CD007872. Epub 2010/07/09.
816. Peters NC, Duvekot JJ. Carbetocin for the prevention of postpartum hemorrhage: a systematic review. Obstet Gynecol Surv. 2009;64(2):129-35. Epub 2009/01/23.
817. McDonald SJ, Middleton P. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database Syst Rev. 2008(2):CD004074. Epub 2008/04/22.
818. Hofmeyr GJ, Abdel-Aleem H, Abdel-Aleem MA. Uterine massage for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2008(3):CD006431. Epub 2008/07/23.
819. Dennehy KC, Rosaeg OP, Cicutti NJ, Krepski B, Sylvain JP. Oxytocin injection after caesarean delivery: intravenous or intramyometrial? Can J Anaesth. 1998;45(7):635-9. Epub 1998/08/26.
820. Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC. Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2001;98(3):386-90. Epub 2001/09/01.
821. Lokugamage AU, Paine M, Bassaw-Balroop K, Sullivan KR, Refaey HE, Rodeck CH. Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon. Aust N Z J Obstet Gynaecol. 2001;41(4):411-4. Epub 2002/01/15.
822. Chou MM, MacKenzie IZ. A prospective, double-blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2 alpha, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section. Am J Obstet Gynecol. 1994;171(5):1356-60. Epub 1994/11/01.
823. George RB, McKeen D, Chaplin AC, McLeod L. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery. Can J Anaesth. 2010;57(6):578-82. Epub 2010/03/20.
824. Svanstrom MC, Biber B, Hanes M, Johansson G, Naslund U, Balfors EM. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. Br J Anaesth. 2008;100(5):683-9. Epub 2008/04/04.
825. Butwick AJ, Coleman L, Cohen SE, Riley ET, Carvalho B. Minimum effective bolus dose of oxytocin during elective Caesarean delivery. Br J Anaesth. 2010;104(3):338-43. Epub 2010/02/13.
826. Sheehan SR, Montgomery AA, Carey M, McAuliffe FM, Eogan M, Gleeson R, et al. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. BMJ. 2011;343:d4661. Epub 2011/08/03.
827. King KJ, Douglas MJ, Unger W, Wong A, King RA. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial. Anesth Analg. 2010;111(6):1460-6. Epub 2010/10/05.
828. Gungorduk K, Asicioglu O, Celikkol O, Olgac Y, Ark C. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial. Aust N Z J Obstet Gynaecol. 2010;50(1):36-9. Epub 2010/03/12.
829. McLeod G, Munishankar B, MacGregor H, Murphy DJ. Maternal haemodynamics at elective caesarean section: a randomised comparison of oxytocin 5-unit bolus and placebo infusion with oxytocin 5-unit bolus and 30-unit infusion. Int J Obstet Anesth. 2010;19(2):155-60. Epub 2010/03/03.
830. Quiroga Diaz R, Cantu Mata R, Tello Gutierrez HE, Puente Villalobos M, Montemayor Garza R, Martinez Mendoza A. [Intrauterine misoprostol for the prevention of bleeding cesarean]. Ginecol Obstet Mex. 2009;77(10):469-74. Epub 2009/11/12. Misoprostol intrauterino para la prevencion de la hemorragia postcesarea.
831. Chaudhuri P, Banerjee GB, Mandal A. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss. Int J Gynaecol Obstet. 2010;109(1):25-9. Epub 2010/01/15.
832. Eftekhari N, Doroodian M, Lashkarizadeh R. The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section. J Obstet Gynaecol. 2009;29(7):633-6. Epub 2009/09/17.
833. Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti AD. Efficacy of tranexamic acid in reducing blood loss after cesarean section. J Matern Fetal Neonatal Med. 2009;22(1):72-5. Epub 2009/01/24.
834. Attilakos G, Psaroudakis D, Ash J, Buchanan R, Winter C, Donald F, et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG. 2010;117(8):929-36. Epub 2010/05/21.
835. Borruto F, Treisser A, Comparetto C. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Arch Gynecol Obstet. 2009;280(5):707-12. Epub 2009/02/21.
836. CRES. Informe Tecnico 125: Efectividad, seguridad y analisis economico de la carbetocina versus la oxitocina para la prevencion de la atonia uterina y hemorragia posparto 2011.
837. Levine AB, Kuhlman K, Bonn J. Placenta accreta: comparison of cases managed with and without pelvic artery balloon catheters. J Matern Fetal Med. 1999;8(4):173-6. Epub 1999/07/16.
838. Alvarez M, Lockwood CJ, Ghidini A, Dottino P, Mitty HA, Berkowitz RL. Prophylactic and emergent arterial catheterization for selective embolization in obstetric hemorrhage. Am J Perinatol. 1992;9(5-6):441-4. Epub 1992/09/01.
839. Mitty HA, Sterling KM, Alvarez M, Gendler R. Obstetric hemorrhage: prophylactic and emergency arterial catheterization and embolotherapy. Radiology. 1993;188(1):183-7. Epub 1993/07/01.
840. Dubois J, Garel L, Grignon A, Lemay M, Leduc L. Placenta percreta: balloon occlusion and embolization of the internal iliac arteries to reduce intraoperative blood losses. Am J Obstet Gynecol. 1997;176(3):723-6. Epub 1997/03/01.
841. Hansch E, Chitkara U, McAlpine J, El-Sayed Y, Dake MD, Razavi MK. Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol. 1999;180(6 Pt 1):1454-60. Epub 1999/06/16.
842. Ojala K, Perala J, Kariniemi J, Ranta P, Raudaskoski T, Tekay A. Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage*. Acta Obstet Gynecol Scand. 2005;84(11):1075-80. Epub 2005/10/20.
843. Bodner LJ, Nosher JL, Gribbin C, Siegel RL, Beale S, Scorza W. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol. 2006;29(3):354-61. Epub 2006/02/28.
844. Tan CH, Tay KH, Sheah K, Kwek K, Wong K, Tan HK, et al. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. AJR Am J Roentgenol. 2007;189(5):1158-63. Epub 2007/10/24.
845. Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115(3):526-34. Epub 2010/02/24.
846. van Beekhuizen HJ, de Groot AN, De Boo T, Burger D, Jansen N, Lotgering FK. Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial. Am J Obstet Gynecol. 2006;194(2):446-50. Epub 2006/02/07.
847. Nardin JM, Weeks A, Carroli G. Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev. 2011(5):CD001337. Epub 2011/05/13.
848. Abdel-Aleem H, Abdel-Aleem MA, Shaaban OM. Tocolysis for management of retained placenta. Cochrane Database Syst Rev. 2011(1):CD007708. Epub 2011/01/21.
849. Chongsomchai C, Lumbiganon P, Laopaiboon M. Prophylactic antibiotics for manual removal of retained placenta in vaginal birth. Cochrane Database Syst Rev. 2006(2):CD004904. Epub 2006/04/21.
850. Baskett PJ. ABC of major trauma. Management of hypovolaemic shock. BMJ.
1990;300(6737):1453-7. Epub 1990/06/02.
851. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG. 2006;113(8):919-24. Epub 2006/08/16.
852. Duthie SJ, Ven D, Yung GL, Guang DZ, Chan SY, Ma HK. Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery. Eur J Obstet Gynecol Reprod Biol. 1991;38(2):119-24. Epub 1991/01/30.
853. Ho AM, Karmakar MK, Dion PW. Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg. 2005;190(3):479-84. Epub 2005/08/18.
854. Hirshberg A, Dugas M, Banez EI, Scott BG, Wall MJ, Jr., Mattox KL. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma. 2003;54(3):454-63. Epub 2003/03/14.
855. Human albumin administration in critically ill patients: systematic review of randomized controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ. 1998;317(7153):235-40. Epub 1998/07/24.
856. Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2011(11):CD001208. Epub 2011/11/11.
857. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2011(3):CD000567. Epub 2011/03/18.
858. Havel C, Arrich J, Losert H, Gamper G, Mullner M, Herkner H. Vasopressors for hypotensive shock. Cochrane Database Syst Rev. 2011(5):CD003709. Epub 2011/05/13.
859. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev. 2007(1):CD003249. Epub 2007/01/27.
860. Buttino L, Jr., Garite TJ. The use of 15 methyl F2 alpha prostaglandin (Prostin 15M) for the control of postpartum hemorrhage. Am J Perinatol. 1986;3(3):241-3. Epub 1986/07/01.
861. Oleen MA, Mariano JP. Controlling refractory atonic postpartum hemorrhage with Hemabate sterile solution. Am J Obstet Gynecol. 1990;162(1):205-8. Epub 1990/01/01.
862. Hofmeyr GJ, Walraven G, Gulmezoglu AM, Maholwana B, Alfirevic Z, Villar J. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG. 2005;112(5):547-53. Epub 2005/04/22.
863. Widmer M, Blum J, Hofmeyr GJ, Carroli G, Abdel-Aleem H, Lumbiganon P, et al. Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial. Lancet. 2010;375(9728):1808-13. Epub 2010/05/25.
864. Blum J, Winikoff B, Raghavan S, Dabash R, Ramadan MC, Dilbaz B, et al. Treatment of postpartum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet. 2010;375(9710):217-23. Epub 2010/01/12.
865. Winikoff B, Dabash R, Durocher J, Darwish E, Nguyen TN, Leon W, et al. Treatment of postpartum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet. 2010;375(9710):210-6. Epub 2010/01/12.
866. Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, et al. Highdose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011;15(2):R117. Epub 2011/04/19.
867. Abdel-Aleem H, Singata M, Abdel-Aleem M, Mshweshwe N, Williams X, Hofmeyr GJ. Uterine massage to reduce postpartum hemorrhage after vaginal delivery. Int J Gynaecol Obstet. 2010;111(1):32-6. Epub 2010/07/06.
868. Ikechebelu JI, Obi RA, Joe-Ikechebelu NN. The control of postpartum haemorrhage with intrauterine Foley catheter. J Obstet Gynaecol. 2005;25(1):70-2. Epub 2005/09/09.
869. Bakri YN, Amri A, Abdul Jabbar F. Tamponade-balloon for obstetrical bleeding. Int J Gynaecol Obstet. 2001;74(2):139-42. Epub 2001/08/15.
870. Chan C, Razvi K, Tham KF, Arulkumaran S. The use of a Sengstaken-Blakemore tube to control post-partum hemorrhage. Int J Gynaecol Obstet. 1997;58(2):251-2. Epub 1997/08/01.
871. Condous GS, Arulkumaran S, Symonds I, Chapman R, Sinha A, Razvi K. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet Gynecol. 2003;101(4):767- 72. Epub 2003/04/12.
872. Akhter S, Begum MR, Kabir Z, Rashid M, Laila TR, Zabeen F. Use of a condom to control massive postpartum hemorrhage. MedGenMed. 2003;5(3):38. Epub 2003/11/06.
873. C BL, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol. 1997;104(3):372-5. Epub 1997/03/01.
874. Hayman RG, Arulkumaran S, Steer PJ. Uterine compression sutures: surgical management of postpartum hemorrhage. Obstet Gynecol. 2002;99(3):502-6. Epub 2002/02/28.
875. Ghezzi F, Cromi A, Uccella S, Raio L, Bolis P, Surbek D. The Hayman technique: a simple method to treat postpartum haemorrhage. BJOG. 2007;114(3):362-5. Epub 2007/01/16.
876. Hwu YM, Chen CP, Chen HS, Su TH. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. BJOG. 2005;112(10):1420-3. Epub 2005/09/20.
877. Kafali H, Demir N, Soylemez F, Yurtseven S. Hemostatic cervical suturing technique for management of uncontrollable postpartum haemorrhage originating from the cervical canal. Eur J Obstet Gynecol Reprod Biol. 2003;110(1):35-8. Epub 2003/08/23.
878. Joshi VM, Otiv SR, Majumder R, Nikam YA, Shrivastava M. Internal iliac artery ligation for arresting postpartum haemorrhage. BJOG. 2007;114(3):356-61. Epub 2007/01/31.
879. Dildy GA, 3rd. Postpartum hemorrhage: new management options. Clin Obstet Gynecol. 2002;45(2):330-44. Epub 2002/06/06.
880. Hong TM, Tseng HS, Lee RC, Wang JH, Chang CY. Uterine artery embolization: an effective treatment for intractable obstetric haemorrhage. Clin Radiol. 2004;59(1):96-101. Epub 2003/12/31.
881. Bloom AI, Verstandig A, Gielchinsky Y, Nadiari M, Elchalal U. Arterial embolisation for persistent primary postpartum haemorrhage: before or after hysterectomy? BJOG. 2004;111(8):880-4. Epub 2004/07/24.
882. Yong SP, Cheung KB. Management of primary postpartum haemorrhage with arterial embolisation in Hong Kong public hospitals. Hong Kong Med J. 2006;12(6):437-41. Epub 2006/12/07.
883. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv. 2007;62(8):540-7. Epub 2007/07/20.
884. Rossi AC, Lee RH, Chmait RH. Emergency postpartum hysterectomy for uncontrolled postpartum bleeding: a systematic review. Obstet Gynecol. 2010;115(3):637-44. Epub 2010/02/24.
885. Shahin AY, Farghaly TA, Mohamed SA, Shokry M, Abd-El-Aal DE, Youssef MA. Bilateral uterine artery ligation plus B-Lynch procedure for atonic postpartum hemorrhage with placenta accreta. Int J Gynaecol Obstet. 2010;108(3):187-90. Epub 2009/12/01.
886. Neilson JP. Interventions for treating placental abruption. Cochrane Database Syst Rev. 2003(1):CD003247. Epub 2003/01/22.
887. Hurd WW, Miodovnik M, Hertzberg V, Lavin JP. Selective management of abruption placentae: a prospective study. Obstet Gynecol. 1983;61(4):467-73. Epub 1983/04/01.
888. Carless PA, Henry DA, Moxey AJ, O’Connell D L, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2006(4):CD001888. Epub 2006/10/21.
889. Catling SJ, Williams S, Fielding AM. Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leucocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section. Int J Obstet Anesth. 1999;8(2):79-84. Epub 2004/08/24.
890. Allam J, Cox M, Yentis SM. Cell salvage in obstetrics. Int J Obstet Anesth. 2008;17(1):37-45. Epub 2007/12/29.
891. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008;36(9):2667-74. Epub 2008/08/06.
892. Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev. 2012;3:CD005011. Epub 2012/03/16.
893. Marti-Carvajal AJ, Comunian-Carrasco G, Pena-Marti GE. Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum. Cochrane Database Syst Rev. 2011(3):CD008577. Epub 2011/03/18.
894. Inaba K, Teixeira PG, Shulman I, Nelson J, Lee J, Salim A, et al. The impact of uncrossmatched blood transfusion on the need for massive transfusion and mortality: analysis of 5,166 uncross-matched units. J Trauma. 2008;65(6):1222-6. Epub 2008/12/17.
895. Cortes A WW, Bolanos F. Reanimacion con globulos rojos Rh positivo y sin prueba cruzada en emergencias medicas. Colombia Medica. 2004;35(4).
896. Ball CG, Salomone JP, Shaz B, Dente CJ, Tallah C, Anderson K, et al. Uncrossmatched blood transfusions for trauma patients in the emergency department: incidence, outcomes and recommendations. Can J Surg. 2011;54(2):111-5. Epub 2011/01/22.
897. Kongnyuy EJ, Mlava G, van den Broek N. Using criteria-based audit to improve the management of postpartum haemorrhage in resource limited countries: a case study of Malawi. Matern Child Health J. 2009;13(6):873-8. Epub 2008/09/10.
898. Deneux-Tharaux C, Dupont C, Colin C, Rabilloud M, Touzet S, Lansac J, et al. Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 clusterrandomised controlled trial. BJOG. 2010;117(10):1278-87. Epub 2010/06/25.
899. Birch L, Jones N, Doyle PM, Green P, McLaughlin A, Champney C, et al. Obstetric skills drills: evaluation of teaching methods. Nurse Educ Today. 2007;27(8):915-22. Epub 2007/03/23.
900. Cook DA, Hatala R, Brydges R, Zendejas B, Szostek JH, Wang AT, et al. Technologyenhanced simulation for health professions education: a systematic review and meta-analysis. JAMA. 2011;306(9):978-88. Epub 2011/09/09.
901. Li XF, Fortney JA, Kotelchuck M, Glover LH. The postpartum period: The key to maternal mortality. International Journal of Gynecology and Obstetrics. 1996;54(1):1-10.
902. Brown S, Small R, Argus B, Davis Peter G, Krastev A. Early postnatal discharge from hospital for healthy mothers and term infants. Cochrane Database of Systematic Reviews. 2002(3).
903. Resolucion 412 de 2000: Por la cual se establecen las actividades, procedimientos e intervenciones de demanda inducida y obligatorio cumplimiento y se adoptan las normas técnicas y guias de atencion para el desarrollo de las acciones de proteccion especifica y detección temprana y la atencion de enfermedades de interes en salud publica, (2000).
904. Resolucion 1043 de 2006: Por la cual se establecen las condiciones que deben cumplir los Prestadores de Servicios de Salud para habilitar sus servicios e implementar el componente de auditoria para el mejoramiento de la calidad de la atencion y se dictan otras disposiciones, (2006).
905. Ley 1122 de 2007.Modificaciones en el Sistema General de Seguridad Social en Salud y otras disposiciones, (2007).
906. Francke AL, Smit MC, de Veer AJ, P M. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC medical informatics and decision making. 2008;8(38).
907. Ley 100 de 1993 : Sistema General de Seguridad Social en Colombia, (1993).
908. Ley 1438 de 2010: Por medio del cual se reforma el Sistema de Seguridad Social en Salud y se dictan otras disposiciones, (2011).
909. Resolucion 3960 de 2008: Manual Estadares de acreditacion. Direcciones Territoriales de Salud, (2008).
910. Manual de Acreditacion en Salud Ambulatorio y Hospitalario, (2011).
911. Resolucion 0123 de 2012: nuevo manual de acreditacion en salud para el ámbito ambulatorio y hospitalario., (2012).
912. Pautas de Auditoria para el Mejoramiento de la Calidad de la tencion en Salud, (2007).
913. Resolucion 2680 de 2007: Por la cual se modifica parcialmente la Resolucion 1043 de 2006 y se dictan otras disposiciones, (2007).
914. Resolucion 3763 de 2007: Por la cual se modifican parcialmente las Resoluciones 1043 y 1448 de 2006 y la Resolucion 2680 de 2007 y se dictan otras disposiciones., (2007).
915. Acuerdo 029 de diciembre de 2011: por la cual se sustituye el acuerdo 028 de 2011 que define, aclara y actualiza integramente el Plan Obligatorio de Salud, (2011).
916. Dodgson M. The management of technological innovation. An international and strategic approach. Oxford2000.